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 Development in the annual killifish Austrofundulus limnaeus can follow two 
distinct developmental trajectories. Typical development includes the entrance of 
embryos into a state of metabolic and developmental arrest termed diapause. Alternately, 
embryos can escape diapause and develop directly without pause. These two trajectories 
are characterized by differences in the rate and timing of developmental, morphological, 
and physiological traits. Insulin and Insulin-like growth factor (IGF) signaling (IIS) is 
known to regulate entrance into diapause in a variety of invertebrates. In this Thesis I 
explore the possible role of IGFs in the regulation of development and diapause in 
embryos of A. limnaeus. Here I report stage-specific expression of IGF-I and II proteins 
and their associated mRNA transcripts. Patterns of IGF-I protein expression are 
consistent with IGF signaling playing a major role in supporting the escape trajectory. In 
addition, treatment of embryos with a potent inhibitor of the IGF-I receptor (IGF1R) 
mimics the diapause developmental pattern even under conditions that should favor direct 
development. Evaluation of mRNA gene expression patterns in the two developmental 
trajectories suggests a role for IGF-I signaling through the RAS-MAPK-ERK pathway, 
which may be promoting the escape phenotype. Additionally, IGF-I activity may be 
enhanced in escape trajectory embryos though upregulation of IGF binding protein 2 
(IGFBP-2) mRNA. These data suggest a major role for IGF signaling in the promotion of 
the escape trajectory, and thus we predict that specific mechanisms are in place in 
diapause-bound embryos that block IGF signaling and thus promote entrance into 
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diapause. The data presented here suggest that blocking IGF signaling is critical for 
induction of diapause, but also suggests that other signaling pathways are likely also at 
play. Other pathways such at the TGF-beta signaling molecules and SMAD pathway, 
may also be involved in the direct regulation of the diapause phenotype, as has been 
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Chapter 1: Introduction 
Development is a highly regulated process of cellular proliferation and 
differentiation. Proper regulation of cellular proliferation relies on the precise timing and 
level of expression of a variety of signaling factors (Bondy, Werner et al. 1990, Dillin, 
Crawford et al. 2002). In addition, target cells must be competent to receive and 
transduce the signals. In almost every case the outcome of these signaling pathways is 
context dependent and may result in growth, differentiation, apoptosis, and even 
developmental arrest (Lowe 1991, Baxter 2000). Developmental arrest, or diapause, has 
been seen in various taxa ranging from nematodes and insects, to fish and mammals 
(Ozanne and Hales 2004, Fielenbach and Antebi 2008). Metabolic dormancy is often 
associated with increased tolerance of environmental stress, and allows for a species to 
persist during times that it would otherwise perish (Vecchio, Soldani et al. 2006, 
Podrabsky, Tingaud-Sequeira et al. 2010). Diapause is initiated through endogenous cues, 
and precedes the onset of unfavorable environmental conditions, and thus embryos enter 
into dormancy under conditions that are conducive to normal development. The 
mechanisms responsible for developmental arrest and the associated increase in 
environmental tolerance are not completely understood in any species. However, the 
insulin-like growth factor (IGF) signaling pathway appears to be involved in the 
regulation of metabolic dormancy in a variety of animals (de Pablo, Perez-Villamil et al. 
1993, Dorman, Albinder et al. 1995, Kimura, Tissenbaum et al. 1997, Cheng 2005). In 
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this thesis I explore the potential role of IGF signaling in the regulation of entrance into 
diapause in embryos of the annual killifish, Austrofundulus limnaeus. 
Austrofundulus limnaeus Development 
Austrofundulus limnaeus, an annual killifish, inhabits ephemeral ponds in 
Venezuela (Podrabsky, Hrbek et al. 1998, Podrabsky 1999). These ponds exist for a few 
months (approximately 1-4 months) during the rainy season, and are dry for the duration 
of the year. Due to the nature of this extreme environment, embryos must arrest their 
development in diapause to extend the time of development to coincide with the return of 
the next rainy season (Podrabsky and Hand 1999) (Figure 1.1). Diapausing embryos 
likely endure severe conditions while embedded in the soil, and have been illustrated in 
the lab to survive large fluctuations in temperature and exposure to UV radiation, anoxia, 
and extreme pHs (Podrabsky, Hrbek et al. 1998, Podrabsky and Somero 2004, 
Podrabsky, Garrett et al. 2010, Podrabsky, Riggs et al. 2015).  
 
Diapause in embryos of Austrofundulus limnaeus 
Diapause in A. limnaeus is a state of developmental and metabolic arrest that 
precedes on the onset of unfavorable environmental conditions (Podrabsky, Riggs et al. 
2015, Podrabsky, Romney et al. 2015). Embryos may arrest development at up to three 
distinct developmental phases termed diapause I, II, and III (Wourms 1972, Wourms 
1972). Diapause I occurs early in development during a specialized developmental period 
in embryos of annual killifish known as the dispersed cell phases (Wourms 1972, 
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Wourms 1972, Wourms 1972). Diapause II may occur midway through development 
after neurulation, but prior to the major phases of organogenesis. Diapause III occurs in 
the late pre-hatching embryo in an essentially fully formed precocious fish larvae. 
Diapause is controlled through endogenous cues, and thus dormancy may occur 
even under conditions that are conducive to development. A great deal is known about 
the biochemical and physiological properties of diapause II in embryos of A. limnaeus. 
During diapause II, A. limnaeus embryos halt growth at Wourms’ Stage (WS) 32-33, 
which is near the end of somitogenesis with 38-40 pairs of somites and just prior to the 
major phases of  organogenesis (Thomerson 1987, Podrabsky 1999, Berois, Arezo et al. 
2015). There is a substantial change in cell numbers, complexity, and metabolic activity 
in diapausing embryos (Podrabsky and Hand 1999). Diapausing embryos have a 
drastically decreased metabolism (>90% reduction) that begins up to 12 days prior to 
developmental arrest (Podrabsky and Hand 1999, Hand and Podrabsky 2000). Oddly, 
there is a significant increase in total DNA content and embryonic complexity during this 
time when metabolism is decreasing. The cell cycle appears to arrest in the G1 phase of 
the cell cycle (Meller, Meller et al. 2012). Embryos exhibit a drastic reduction in heart 
rate relative to non-diapausing embryos at the same stages (Podrabsky, Garrett et al. 
2010). 
 
Alternative developmental trajectories in embryos of A. limnaeus 
Entrance into diapause II is an alternative developmental trajectory that can be 
regulated by both maternal inputs and the developmental environment experienced by the 
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embryo (Podrabsky, Garrett et al. 2010, Podrabsky, Romney et al. 2015). Embryos can 
also develop directly to hatching, thus allowing the completion of their entire lifecycle 
during a single rainy season (Wourms 1972, Podrabsky, Garrett et al. 2010, Podrabsky, 
Romney et al. 2015). These direct-developing embryos were termed “escape” embryos 
because they escape dormancy in diapause II (Wourms 1972). These two trajectories 
represent a bet hedging strategy (King and Masel 2007) that has been observed in many 
species that inhabit extreme or unpredictable environments, because it decreases risk of 
extinction by producing offspring of two different phenotypes. Escape embryos provide 
the potential for multiple spawning generations during a single rainy season, while 
diapausing embryos ensure survival of the population through to the next rainy season.  
Evidence exists that maternal influences can control development along the 
diapause or escape trajectory (Podrabsky, Garrett et al. 2010). Young females tend to 
produce embryos that develop along the escape trajectory, while older females tend to 
produce a large proportion of embryos that enter diapause II. However, conditions 
experienced by the embryos can override this maternal input. Temperature appears to 
have a major effect on development trajectory, with temperature of 25˚C and lower 
favoring diapause II. In contrast, an incubation temperature of 30˚C favors development 
along the escape trajectory (Podrabsky, Garrett et al. 2010) (Figure 1.2).  
Development along the two trajectories may result in different biochemical and 
physiological capacities at the completion of development. Chennault and Podrabsky 
(2010) found that A. limnaeus embryos in diapause II and escape embryos develop at 
different rates and complete development with different enzymatic capacities in both 
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anaerobic and aerobic metabolic pathways. Embryos that enter and exit from diapause II 
have an increased capacity for citrate synthase and lactate dehydrogenase activity relative 
to the escape embryos of the same developmental stage.  
 
IGF signaling in metabolic dormancy 
Cellular metabolism, growth, and proliferation are severely down-regulated in 
organisms that arrest development (Rahman and Thomas 2014). The mechanisms 
responsible for developmental arrest are not completely understood in any species, but a 
wealth of evidence points to the central importance of IGF signaling in regulating 
entrance into metabolic dormancy. For example, it has been shown in Caenorhabditis 
elegans nematodes that down-regulation of DAF-2 (the C. elegans homolog of IGF1R) 
plays a crucial role in regulating entrance into dormancy as a “dauer” larvae (Kimura, 
Tissenbaum et al. 1997, Guo, Rena et al. 1999, Bonafe, Barbieri et al. 2003). In addition, 
IGF levels are decreased in red snapper, Lutjanus campechanus, in response to metabolic 
depression associated with hypoxic stress (Rahman and Thomas 2014). I hypothesize that 
IGF expression and signaling plays a crucial role in the regulation of dormancy in 
vertebrates, and specifically in diapausing embryos of A. limnaeus.  
The IGF signaling pathway in C. elegans (Figure 1.3) shares many similarities 
with vertebrate IGF signaling (Figure 1.4), but is also unique in many ways. The C. 
elegans pathway is simplified compared to vertebrates, and thus may be useful as a 
construct from which to build a more coherent picture of the important aspects of IGF 
signaling. In C. elegans, extracellular IGF binds to a transmembrane bound receptor 
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protein called DAF-2. Ligand binding to DAF-2, induces autophosphorylation which 
activates the receptor and leads to phosphorylation of multiple substrates, such as the 
subunits of Age-1 (the PI3K equivalent) (Dorman, Albinder et al. 1995, Kimura, 
Tissenbaum et al. 1997). IGF signaling in C. elegans works mainly through activation of 
AKT1/2, which can affect many subsequent pathways. Active AKT suppresses the action 
of proteins such as DAF-16 (FOXO homolog), which leads to increased protein synthesis 
and cell growth (Kimura, Tissenbaum et al. 1997, Pierce, Costa et al. 2001, Fielenbach 
and Antebi 2008). Additionally, AKT activates pathways that lead to increased glucose 
metabolism, cell growth and survival, mobility, and blocks pathways that activate 
apoptosis. However, when larvae sense reduced food availability, IGF signaling is 
downregulated, which allows for increased activity of DAF-16 due to reduced activity of 
AKT. DAF-18, (a PTEN homolog), is also activated by low IGF signaling which leads to 
lower activity of PDK-1 and AKT (Ogg and Ruvkun 1998). DAF-18 thus facilitates an 
increase in DAF-16 activity. DAF-16 appears to be the major effector protein that 
induces the physiological phenotype associated with dauer formation (Lin, Hsin et al. 
2001, Hesp, Smant et al. 2015). 
 
Insulin-like growth factors in vertebrates 
IGFs are powerful regulators of growth and development in vertebrate and non-
vertebrate organisms. There are two basic IGFs that are found in all vertebrates, and both 
regulate cellular growth, division, differentiation, and migration (Lowe 1991). IGF-II 
activity has been associated with early embryonic development, but it is also known to 
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persist at much lower levels through adulthood (Scott, Cowell et al. 1985, Lowe 1991, 
Chastant 1994). In contrast, IGF-I is associated with later embryonic development and 
adulthood (O'Dell and Day 1998). In adults, IGFs are produced in the liver, muscle, 
brain, and bone and are delivered to all cells through the circulatory system. Regulation 
of IGF activity and IGF signaling is complex and includes a variety or transcriptional, 
and post-translational levels of control. 
IGFs are transported in the blood as free hormone, or bound to IGF binding 
proteins (IGFBPs) that extend their half-life and typically lead to increased action 
(Clemmons 1991). Free IGFs bind to dimers of insulin-like growth factor I receptor 
(IGF1R), insulin receptor (IR), or heterodimers of the two. Binding to the receptor causes 
autophosphorylation that activates kinase activity of the cytoplasmic portion of the 
receptor (Felder, Miller et al. 1990). Phosphorylation of the receptor leads to the 
recruiting of IR adaptor proteins and other downstream proteins, that ultimately lead to 
the activation of several important intracellular signaling cascades (e.g. mTOR, AKT, 
MAPK) (White and Yenush 1998, Oldham and Hafen 2003). The activation of the AKT 
signaling pathway results in increased cell survival, metabolism, protein synthesis, and 
growth. Additionally, IGF1R activates the MAPK pathway that results in the activation 
of ERK. ERK activates a number of different proteins such as FOXM1, AP-1, ELK1 and 
others that typically lead to the activation of genes that lead to increased cell survival, 
metabolism, protein synthesis, and growth (Kim and Chung 2002, Liang and Slingerland 
2003, Milton, J Dirk et al. 2008, Hers, Vincent et al. 2011). The exact effects of IGF 
signaling are context-dependent and can be altered by previously received signals.  
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Many of the processes that are regulated by a single IGF pathway in C. elegans, 
are regulated by other means in vertebrates. For example, in C. elegans the IGF pathway 
is responsible for regulation of the activity of genes involved in glucose metabolism 
(Ruvkun 1998). In vertebrates this activity is regulated mainly by insulin through binding 
to insulin receptor (Saltiel and Kahn 2001, Chang, Chiang et al. 2004). IGFs in 
vertebrates do have some control over the activity of genes involved in glucose 
metabolism, but these signaling cascades are activated much more weakly through 
IGF1R signaling compared to that observed through insulin receptors. There is cross 
reactivity in vertebrates between IGFs and IR, but insulin has a much higher affinity for 
IR than IGFs (Werner, Weinstein et al. 2008). Additionally, there is a third receptor in 
vertebrates, IGF2R (also called cation-independent mannose-6-phosphate receptor), 
which is not found in C. elegans. Unlike the other insulin family receptors, IGF-2 is the 
only insulin/IGF ligand that has been found to bind to IGF2R. IGF2R appears not to 
transduce a signal, but rather leads to IGF-II degradation and thus attenuation of IGF 
signaling through IGF-II. Binding of IGF-II to IGF2R leads to endocytosis and formation 
of an endosome where IGF-II is released and degraded, while IGF2R is then recycled and 
transported back to the plasma membrane (Ghosh and Kornfeld 2004) (See Figure 1.5). 
In vertebrates, production and secretion of IGFs is stimulated by growth hormone 
(GH). In adult vertebrates, IGFs are produced primarily by hepatic tissue, but during 
embryogenesis, prior to liver formation, IGFs are produced globally (Lowe 1991, 
Nissley, Kiess et al. 1991). GH binds to growth hormone receptor (GHR), which 
phosphorylates Janus kinase 2 (Jak2). Activation of Jak2 ultimately results in the 
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activation of the genomic effects of GH signaling by inducing transcription through the 
phosphorylation of signal transducer and activator of transcription factor proteins 1, 3, 
and 5 (STAT 1, 3, and 5). STAT proteins dimerize and activate transcription of numerous 
genes that inhibit apoptosis, activate the cell cycle and proliferation, and induce 
differentiation. Increased transcription of mRNAs for IGFs is one major effect of GH 
signaling (Figure 1.6). GH will also affect the MAPK signaling and PI3K-AKT pathway, 
as does IGF (Cassoni, Papotti et al. 2001). GH also has non-genomic effects on cell 
physiology including the stimulation of IGF secretion.  
IGF expression is essential to normal development in many organisms. In 
Xenopus embryos, it was found that expression of IGFs in the anterior region leads to 
head development through inactivation of Wnt signaling, while IGF1R diminution with 
antisense oligonucleotides radically reduces cranial structures (Pera, Wessely et al. 2001, 
Richard-Parpaillon, Heligon et al. 2002). Furthermore, IGF-I and II are capable of 
stimulating cellular proliferation and differentiation in a variety of tissues such as mouse 
skeletal muscles and myoblast cells (Tollefsen, Lajara et al. 1989).  
In addition to their normal function as regulators of cell growth and proliferation 
throughout life, IGFs are also recognized as mitogens promoting the growth of various 
cancerous tumors (Froesch, Schmid et al. 1985, Macaulay 1992, Renehan, Zwahlen et al. 
2004). There are vast amounts of data showing a link between cancerous cellular 
proliferations in different types of cancer and IGF dysregulation. Renehan (2004) found 
in a meta-analysis, which included 3609 cases and 7137 control individuals, that high 
concentrations of IGF-I were associated with an increase in prostate and premenopausal 
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breast cancer in humans. In 1998, Ma found that IGF-I levels correlated with an increased 
risk of colorectal cancer in humans (Ma, Pollak et al. 1999). Samani (2007) reports an 
association with increased levels of IGFs in various cancers in humans including: 
ovarian, endometrial, prostate, seminoma, osteosarcoma, gallbladder, renal cell 
carcinoma, glioma, astrocytoma, meningioma, meduloblastoma, colon, gastric, 
gastrinomas, pancreatic, hepatoma, liver, hepatocellular carcinoma, lung cancer, thyroid, 
and breast cancers. Increases in levels of IGF-I, II, or both have been reported in various 
cancers compared to normal tissue (Samani, Yakar et al. 2007). A study of age-associated 
proteotoxity and Alzheimer Disease in mice has shown that IGF-I signaling plays an 
important role in this disease as well. Transgenic mice with reduced IGF receptor 
signaling and Alzheimer Disease lived longer and had reduced neuroinflammation 
compared to age-matched Alzheimer Disease mice (Cohen, Paulsson et al. 2009). 
IGF signaling has been shown to play a critical role in the aging process in 
vertebrates and invertebrates, and has received a great deal of attention in C. elegans 
(Daniel and Krishnan 1969, de Pablo, Perez-Villamil et al. 1993, Kimura, Tissenbaum et 
al. 1997, Tissenbaum and Guarente 2001). Originally, aging was considered to be a 
passive process—meaning deterioration occurred in an entropic random way (Kenyon 
2010). It was chaotic. However, modern theory suggests that aging can be placed into 
two categories: programmed and damage related. Damage related factors stem from 
environmental stresses that require coping mechanisms to prevent or repair damage. 
From yeast to primates, caloric restriction has been shown to extend lifespan and reduce 
the aging process (Colman, Anderson et al. 2009). Programmed aging implies that cells 
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are following a timetable that perhaps is just a prolonged aspect of development and 
growth. There are several subcategories within these two theories, and in reality both 
likely work together to determine the longevity of an organism.  
There are many classical signaling pathways that are associated with aging, such 
as TOR, AMP kinase, sirtuins, and IGFs (Rogina and Helfand 2004, Greer, Dowlatshahi 
et al. 2007, Greer and Brunet 2009). Because of their critical roles in regulating cell 
growth and metabolism in all life stages, IGFs are excellent candidates for regulating the 
programmed aspects of organismal aging. Transgenic male mice which expressed 
increased Sirt6 had reduced IGF-I serum levels with increased IGFBP, but also increased 
lifespan compared to male mice with lower Sirt6 expression and higher IGF-I expression 
(Kanfi, Naiman et al. 2012) suggesting that high expression of IGFs and/or activation of 
the IGF pathway causes an acceleration in the rate of the aging process 
IGFs are an important group of molecular signals that if understood could help 
lead to better cancer treatments (Denduluri, Idowu et al. 2015) and potentially lead to an 
extension of life or an increase in the quality of life in humans through decreasing 
diseases associated with aging (chronic kidney disease, diabetes mellitus, chronic 
obstructive pulmonary, and cardiovascular disease) and other features of aging (muscle 




Insulin-like growth factors and regulation of development in A. limnaeus 
IGF-I and –II ligands and the IGF signaling pathway are an interesting target for 
research on the regulation of diapause in A. limnaeus due to their importance in 
regulating cellular growth, proliferation, and aging. Insights gained from studying IGF 
expression and regulation in A. limnaeus can inform how IGFs and IGF signaling 
pathways change with regard to rapid as compared to arrested development.  
The annual killifish, Austrofundulus limnaeus, offers a unique model system for 
addressing the role of IGFs in the control of arrested development (Wourms 1972). The 
presence of alternative developmental trajectories within a single species that can be 
experimentally manipulated allows for controlled experiments to be conducted within the 
same genomic background. We hypothesize that IGF expression and activity will regulate 
the cellular events associated with entrance into developmental arrest in this species. 
In this thesis, I detail the developmental pattern of IGF protein expression using 
enzyme-linked immunosorbent assays (Wilkinson, Elliott et al. 2004) in both diapause 
and escape embryos at various developmental stages (staging determined using Wourms’ 
Stages for killifish) (Wourms 1972, Wourms 1972). I predict that there will be 
differential expression of IGFs in the two trajectories: the diapausing embryos will have 
lower amounts of IGF proteins, while higher amounts of IGF proteins will be expressed 
in escape embryos. I attempt to override the predicted developmental trajectory of an 
embryo through pharmacological manipulation of IGF signaling. Additionally, I attempt 
to create a more global image of IGF signaling and how it may be important in the 
regulation of developmental trajectory in this species using transcriptomic data obtained 
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from embryos developing along the escape and diapause trajectories. This thesis 
illustrates that: (1) there are quantifiable differences in IGF expression between diapause 
and escape embryos, (2) inhibition of IGF1R activity can mimic development along the 
diapause trajectory even under conditions that should favor development along the escape 
trajectory, and (3) differential expression of genes involved in the IGF signaling pathway 





Figure 1.1. The Lifecycle of the Austrofundulus limnaeus Killifish. 
At the onset of the rainy season, which lasts for 3-4 months, larvae hatch and develop rapidly to 
sexual maturity. After reaching sexual maturity, adults breed daily and produce embryos that are 
embedded in the sediment. At this point embryos can proceed down two trajectories: diapause or 
escape. Continuous embryonic development may be interrupted by diapause at each of three 
distinct stages of diapause, termed diapause I, II, and II: Diapause I can occur at WS 22 during 
dispersion of cells after full epiboly, diapause II can occur at WS 32-33 when the embryo 
develops 38-40 somites, and diapause III can occur at WS 43 in a prehatching embryo that is fully 
formed and waiting for the right signals to hatch. The most common form of diapause found in A. 










Figure 1.2. Temperature effects on developmental trajectory.  
Austrofundulus limnaeus embryos reared at different temperatures will develop along two 
different developmental trajectories. Embryos incubated at 25˚C will develop mainly along the 
diapause trajectory (80-90%). When incubated at 20˚C, 100% of embryos develop along the 
diapause trajectory, while 100% of those reared at 30˚C develop as escape embryos (Podrabsky, 



















Figure 1.3. Simplified IGF signaling pathway in Caenorhabditis elegans.  
Insulin-like protein signaling results in the activation of AKT, which acts to regulate a variety of 
factors and pathways to promote cell growth and proliferation. The main effector of dormancy in 
C. elegans appears to be release of inhibition of DAF-16 (FOXO homolog) in the absence of 
strong IGF signaling. Active DAF-16 results in many of the physiological phenotypes associated 
with dauer dormancy. Arrows depict activation, while lines depict inhibition. IGF – insulin-like 
growth factor; DAF-2 – insulin-like growth factor 1 receptor/insulin receptor homolog; IGFBP – 
insulin-like growth factor binding protein; IST-1 – insulin receptor substrate homolog; p85 and 
p110homolog – regulatory and catalytic subunits of AGE-1, respectively; PIP2 and PIP3 - 
Phosphatidylinositol 4,5-bisphosphate and Phosphatidylinositol (3,4,5)-trisphosphate ; DAF-18 - 
Phosphatase and tensin homolog (PTEN) tumor suppress homolog; PDK1 - Phosphoinositide-
dependent kinase-1; AKT – Protein Kinase B; SGK – Serine/threonine-protein kinase; TSC1/2 – 
Tuberous sclerosis 1 and 2; mTOR – mechanistic target of rapamycin; RICTOR – Rapamycin-
insensitive companion of mTOR; Deptor – DEP domain-containing mTOR-interacting protein; 
PROTOR – Proline-rich protein 5-like; mSin1 – Target of rapamycin complex 2 subunit 
MAPKAP1; MLST8 – Target of rapamycin complex subunit LST8; TTI1 – TELO2-interacting 
protein 1 homolog; TEL2 – Telomere length regulation protein; RAPTOR – Regulatory-
associated protein of mTOR; pras40 – Proline-rich AKT1 substrate 1; CED9 – Apoptosis 
regulator ced-9; BAD – Bcl2-associated agonist of cell death; GSK-3Beta – Glycogen synthase 
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kinase-3 beta; DAF-16 – Forkhead Box O homolog; and S6K – Ribosomal protein S6 kinase 














Figure 1.4. Simplified insulin-like growth factor signaling pathway in vertebrates. 
Insulin-like growth factor signaling can be initiated through two different receptors, IGF1R and 
IR, as well as heterodimers of these two receptors. IGF-II can also be degraded through binding 
to the IGF2R. Activation of IGF signaling can activate at least two known pathways in 
vertebrates. One pathway activates AKT, in a fashion similar to that known to occur in C. 
elegans. In addition, IGF signaling can act through the ERK pathway and activation of AP-1 (c-
Jun/c-Fos) transcriptional activation. The outcome of IGF signaling is similar in C. elegans and 
vertebrates. IGF – insulin-like growth factor; IGF1R – insulin-like growth factor 1 
receptor/insulin receptor homolog; IGFBP – insulin-like growth factor binding protein; IRS – 
insulin receptor substrate; p85 and p110homolog – regulatory and catalytic subunits of PI3K, 
respectively; PIP2 and PIP3 - Phosphatidylinositol 4,5-bisphosphate and Phosphatidylinositol 
(3,4,5)-trisphosphate ; PTEN - Phosphatase and tensin homolog tumor suppressor; PDK1 - 
Phosphoinositide-dependent kinase-1; AKT – Protein Kinase B; IKK – Inhibitor of nuclear factor 
kappa-B kinase; SGK – Serine/threonine-protein kinase; AMPK – 5’-AMP-activated protein 
kinase;TSC1/2 – Tuberous sclerosis 1 and 2; mTOR – mechanistic target of rapamycin; RICTOR 
– Rapamycin-insensitive companion of mTOR; Deptor – DEP domain-containing mTOR-
interacting protein; PROTOR – Proline-rich protein 5-like; mSin1 – Target of rapamycin complex 
2 subunit MAPKAP1; MLST8 – Target of rapamycin complex subunit LST8; TTI1 – TELO2-
interacting protein 1 homolog; TEL2 – Telomere length regulation protein; RAPTOR – 
Regulatory-associated protein of mTOR; pras40 – Proline-rich AKT1 substrate 1; BCL-2 – 
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Apoptosis regulator; BAD – Bcl2-associated agonist of cell death; GSK-3Beta – Glycogen 
synthase kinase-3 beta; FOXO – Forkhead Box O; and S6K – Ribosomal protein S6 kinase; p27 – 
Cyclin-dependent kinase inhibitor; SHC – ; GRB2 – Growth factor receptor-bound protein 2; 
SOS – Son of seven; RAS – GTPase; RAF – RAF proto-oncogene serine/threonine-protein 
kinase; MEK 1/2 - Dual specificity mitogen-activated protein kinase; ERK – Mitogen-activated 
protein kinase; - FOXM1 – Forkhead Box M1; CDC25A – M-phase inducer phosphatase; CDK2 
– Cyclin-dependent Kinase 2; AP-1 - AP-1 transcription factor; c-Jun and c-Fos – c-Jun and c-


































Figure 1.5. Simplified insulin-like growth factor signaling through the insulin and insulin-
like growth factor 2 receptors.  
Insulin-like growth factors can bind to two other possible receptors, the insulin receptor (IR) and 
the insulin-like growth factor 2 receptor (IGF2R). IR can be bind insulin, IGF-I, or –II. IGF2R 
only binds with IGF2. IR activates a similar pathway as IGF1R, but it does not appear to have the 
same capacity for growth, differentiation, and proliferation, and has more of an effect on 
metabolism than IGF1R (Werner, Weinstein et al. 2008). IR also has a much higher affinity for 
insulin than either IGF-I or –II. IGF2R only binds IGF-II, to induce IGF-II degradation (Nissley, 





















Figure 1.6. Simplified growth hormone signaling pathway. 
Growth hormone (GH) signaling results in the activation of STAT-dependent transcription 
through the JAK-STAT signaling pathway as well as the AKT signaling pathway. Activation of 
STAT proteins leads to increased transcription of mRNAs for insulin-like growth factors I and II 
(IGFs). IGFs are secreted if GH signaling continues or are sequestered until GH signaling occurs 










Chapter 2: Insulin-like Growth Factor Protein Expression Profiles of Diapause II 
and Escape Embryos of Austrofundulus limnaeus 
 
Abstract 
 In nearly all vertebrates, embryogenesis is a continuous process, however, some 
species have evolved mechanisms to reversibly halt development. One such species is 
Austrofundulus limnaeus, a killifish endemic to ephemeral ponds in Venezuela. A. 
limnaeus embryos enter diapause II (DII), a state of metabolic and developmental arrest 
promoted by endogenous cues, midway through development at approximately 24 days 
post-fertilization when incubated at 25ºC (Wourms’ Stage (WS) 32-33). As embryos 
enter diapause, heart rate declines causing blood to pool in the vasculature and 
morphogenesis is put on hold. Additionally, A. limnaeus embryos can develop down an 
alternative pathway where embryos “escape” from diapause and develop directly. To 
investigate developmental signaling factors associated with escape embryogenesis, I 
examined expression of insulin-like growth factor (IGF) proteins (I and II) in embryos 
developing along the escape and diapause trajectories. Embryos were incubated at two 
temperatures, one that favors entrance into diapause II (25ºC) and one that favors escape 
embryos (30ºC). Embryos were sampled throughout development, and relative expression 
of IGF proteins was determined by enzyme linked immunosorbent assay (ELISA). IGF-I 
expression peaks early in development in embryos developing along the escape 
trajectory, while in embryos on the diapause pathway IGF-I expression is muted until 
post-diapause II development. In addition, IGF-II protein levels are higher in newly 
23 
fertilized embryos that are destined to develop along the escape trajectory. These data 
suggest a role for increased IGF signaling in the promotion of the escape developmental 
trajectory. Both IGF-I and IGF-II expression is higher at the end of development in post-
diapause II embryos suggesting a role for increased IGF signaling in the support of 
compensatory developmental acceleration that is observed in post-diapause II 
development for this species. These suggest a critical role for IGF signaling in the 


















The Annual killifish Austrofundulus limnaeus 
 The killifish, Austrofundulus limnaeus, is an annual species – a group of fishes 
that spend their entire life in temporary bodies of water. These bodies of water are filled 
during the local rainy season, but desiccate afterwards, existing as dry, depressions of 
cracked mud for most of the year (Myers 1952, Peters 1963, Wourms 1972, Wourms 
1972). During the dry season the juvenile and adult fish die due to a variety of factors 
including increased predation and natural causes (Nico and Thomerson 1989). Post-
embryonic life in this species appears adapted for survival and reproduction in the 
temporally limited environment, which includes rapid growth, very early sexual 
maturation, and high fecundity (Podrabsky 1999). In contrast to post-embryonic 
development, embryonic development in the species is relatively slow and prolonged 
compared to similar species with similar sized eggs; This is presumably an adaptation for 
survival of the dry season. The species persists through the dry season as embryos 
deposited into the substrate of the pond beds. Individuals may spend the majority of their 
lifetime as an embryo encased in drying mud, and only a few short months in post-
embryonic life stages.  
Embryos of A. limnaeus prolong development in two distinct ways. First, they 
develop slowly, taking almost a month to complete developmental processes that are 
completed within a few days in similar closely related species (Wourms 1972, Podrabsky 
1999). Second, they can enter into a state of arrested development termed diapause in up 
to three embryonic stages. Entrance into diapause is associated with a decreased 
25 
metabolic rate, inhibition of the cell cycle and cell growth, and cessation of 
morphological development (Podrabsky and Hand 1999, Podrabsky and Hand 2000). 
Entrance into diapause II is common in A. limnaeus, and is the focus of this study (Hand 
and Podrabsky 2000). Importantly, there is an alternative pathway of development in A. 
limnaeus, where embryos “escape” from diapause II (Wourms 1972, Wourms 1972). 
Escape embryos develop without pause and complete their entire embryonic development 
without arresting. It is possible that escape embryos could complete their entire lifespan 
within one rainy season, rather than enduring the harsh conditions imposed by the dry 
season. This ecological trade-off has clear implications for survival of an individual and 
survival of the species. Thus, the pathways that regulate these critical developmental 
decisions are likely to be under intense selection pressure. Insulin-like growth factors are 
known to play major roles in the regulation of developmental growth and differentiation 
(Furstenberger and Senn 2002, Vincent and Feldman 2002, Oldham and Hafen 2003) and 
have been implicated in the regulation of diapause-like states in other organisms 
(Kimura, Tissenbaum et al. 1997, Kenyon 2001, Kenyon 2010). Thus, here I detail the 
expression of insulin-like growth factor proteins during development and diapause in 
embryos of A. limnaeus to assess a possible role for these critical signaling hormones in 
regulating developmental trajectories associated with diapause. 
 
Insulin-like Growth Factors in Development and Diapause 
Insulin-like growth factors are protein hormones excreted via exocytosis into the 
extracellular space (Nissley, Kiess et al. 1991). When no circulatory system is present, 
26 
these proteins act as autocrine or paracrine signals. However, in embryos and adults with 
a circulatory system the proteins largely act via endocrine signaling (Lowe 1991). IGF 
transcription, translation and excretion is typically stimulated by growth hormone 
signaling in adult tissues (Carter, Ramsey et al. 2002, Salvatori 2004). In larvae and 
adults, hepatic (liver) cells are the primary producers of IGFs while a small amount is 
produced in the brain for local signaling. However, in embryonic tissues, IGFs are 
produced globally—meaning various cells with different lineages will produce IGFs 
throughout the entire embryo (Lowe 1991, Nissley, Kiess et al. 1991, Rosen and Pollak 
1999). 
 IGF proteins and their associated signaling pathways are highly conserved across 
vertebrates (Greene and Chen 1997, Kenyon 2001). The IGF family includes IGF-I and 
IGF-II proteins, which bind to and signal through the IGF 1 receptor (IGF1R) (Hsu, Chiu 
et al. 2008, Hsu and Chiu 2009). IGFs have been shown to regulate various aspects of 
development in invertebrate and vertebrate embryos. IGF signaling is almost always 
associated with increased growth and differentiation. Upregulation of this pathway is 
found in growth in vertebrates from humans (Furstenberger and Senn 2002, Oldham and 
Hafen 2003, Salvatori 2004) to chickens (de Pablo, Perez-Villamil et al. 1993) to 
zebrafish (Eivers, McCarthy et al. 2004, Kajimura, Aida et al. 2005, Kamei, Ding et al. 
2011). Liu et al. (1993) showed that mutant mice that lacked IGF1R (IGF1R -/-), grew to 
only 45% of normal birth weight compared to wildtype. Additionally, IGF-II null mutants 
grew to only 60% of normal birth weight. Double mutants IGF-II(-/-)IGF-I(-/-) suffered 
further depression of growth reaching only 30% of normal birth weight (Liu, Baker et al. 
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1993). In addition to their crucial role in regulating developmental growth, IGFs are also 
important differentiation factors, such as the case with skeletal muscle satellite cells. IGF-
I and -II have been shown to induce differentiation in mice skeletal muscle and myoblast 
cell lines via autocrine and paracrine signaling (Tollefsen, Lajara et al. 1989, Tollefsen, 
Sadow et al. 1989).  
 The strong action and highly conserved role of IGFs in supporting cellular growth 
and proliferation suggests that downregulation of IGF signaling must be a critical aspect 
of entrance into metabolic and developmental arrest associated with embryonic diapause. 
There is evidence already for IGF regulation being a crucial factor in dormancy in C. 
elegans through regulation of the IGF1R (DAF-2). Entrance into dauer dormancy in C. 
elegans, a diapause-like state, is regulated by reduction of IGF signaling through IGF1R 
(DAF-2), and an associated increased activity of the transcription factor FOXO (DAF-16) 
(Lin, Hsin et al. 2001). In addition, FOXO has been shown to be a regulator of diapause 
in the mosquito Culex pipiens and Drosophila melanogaster (Puig, Marr et al. 2003, Sim 
and Denlinger 2008). Downregulation of IGF and upregulation of FOXO is thought to 
create conditions that protect an organism during times of environmental stress such as 
anoxia or low food (Sim, Kang et al. 2015). 
 
IGFs and compensatory growth during development 
Under natural conditions, developing embryos are likely to experience 
environmental or genetic stress that results in the retardation of growth or even a pause or 
arrest of development (Tamemoto, Kadowaki et al. 1994, Gillooly, Charnov et al. 2002, 
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Soto, Bazaes et al. 2003, Koide, Hayata et al. 2005, Saenger, Czernichow et al. 2007). 
When embryos then return to conditions that support growth and the continuation of 
development, they often show an acceleration in growth and developmental rate that has 
been referred to as “catch-up” or “compensatory” growth (Wilson and Osbourn 1960). 
This has been reported in animals as diverse as the nematode C. elegans, fish, and 
mammals (Ozanne and Hales 2004, Fielenbach and Antebi 2008, Kamei, Ding et al. 
2011). The wide range of animals that exhibit this phenomenon suggests a highly 
conserved mechanism for embryonic growth in response to stress. There are two models 
that have been proposed to explain catch-up growth (Finkielstain, Lui et al. 2013). 
Systemic regulation theory proposes the central nervous system compares actual body 
size with developmental stage and adjusts growth and developmental rate according to 
what is age appropriate using the endocrine system (Tanner 1963, Kamei, Ding et al. 
2011). The second theory proposes cell-autonomous regulation at each peripheral organ 
and tissue (Tanner 1963, Boersma, Houwen et al. 2002). However, it is also argued that a 
combination of local and systemic mechanisms working together that drive tissues 
towards catch-up growth (Finkielstain, Lui et al. 2013). While the exact model of action 
is still debated, there is concrete evidence that insulin-like growth factors I and II (IGF-I, 
IGF-II) and the IGF signaling pathway play a crucial role in catch-up growth (Kamei, 
Ding et al. 2011). 
This project quantified the levels of IGF-I and -II protein using an enzyme-linked 
immunosorbent assay (ELISA), IGF levels were quantified during development and 
differentiation of two alternative developmental trajectories, direct-developing “escape” 
29 
embryos and embryos developing and arresting in diapause. We hypothesize that escape 
embryos produce more IGFs throughout early development than diapausing embryos. 
 
Material and Methods 
Animal Care and Embryo Collection 
Embryos were harvested from a laboratory stock of A. limnaeus, originally 
collected in 1995 from the ephemeral ponds of Maracaibo basin located in Northwestern 
Venezuela (Podrabsky, Hrbek et al. 1998). Detailed methods for the husbandry of adults 
and collection of embryos have been previously established (Podrabsky 1999). Adults 
were housed in glass aquaria with a density of one spawning pair, one male and one 
female, in each 10 l tank. Individual tanks were connected to a common sump equipped 
with mechanical, chemical, and biological filtration. Ten percent of the system water was 
changed twice a day using dechlorinated, UV treated, 10 micron filtered City of Portland 
tap water (from the Bull Run Watershed) that was supplemented with 1 ppt Coral Life 
sea salt (Podrabsky 1999). The fish were fed twice a day with either bloodworms or 
earthworms. Water temperature was maintained at approximately 26˚C, with photoperiod 
was maintained at 14hrs of light and 10hrs of dark.  
 Embryos were collected twice a week, Monday and Thursday, for approximately 
2 hours. This interval was found to provide the highest embryo yield and quality 
(Podrabsky 1999). Embryos were collected through natural spawning activity into trays 
of glass beads (500 µm) as previously described. 
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Embryos were sampled from the combined output of 42 spawning pairs of fish. A 
total of 600 were taken from each spawning date, and 300 embryos were placed into two 
temperature treatment groups of 25˚C or 30˚C. Embryos were incubated in 100 mm x 20 
mm plastic culture dishes at a density of 50 embryos or less per dish. Embryo medium 
(Podrabsky, 1999) containing methylene blue (0.0001%) was used for the first 4 days of 
development to hinder fungal growth. After four days, the embryos were bleached with 
sodium hypochlorite (2, 5 min washes with 0.02% with a 5 min rest between), and then 
transferred into embryo medium containing 10 mg/l gentamicin sulfate (Podrabsky 
1999). Medium was changed and dead embryos were removed every 24 hr. Incubation 
temperature was controlled by placing the embryos in incubators at their corresponding 
temperatures in complete darkness (Podrabsky 1999). Every two days post-fertilization 
(dpf), embryos were inspected and staged according to Wourms (1972) using an inverted 
microscope (WS = Wourms’ Stage). Embryos were sampled from the 25˚C and the 30˚C 
groups for each developmental stage at each temperature. Embryos were flash frozen 
individually in liquid nitrogen, and then stored in a -80˚C freezer until protein extraction 
and quantification.  
 
Identification and sampling of escape and diapause II trajectory embryos 
Freshly fertilized embryos at the 1-2 cell stage were classified as diapause or 
escape trajectory through the monitoring of individual female reproductive output. 
Immediately after embryo collection, most of the embryos produced by a female (all but 
10-20 embryos) were flash frozen in liquid nitrogen. A subset of each of these clutches of 
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embryos from each female were then monitored using an inverted compound microscope 
to determine the ratio of embryos that developed along the diapause and escape 
trajectories when incubated at 25ºC. Clutches of embryos that resulted in 100% diapause 
or 100% escape embryos were used to represent embryos maternally programmed for the 
diapause or escape trajectories.  
 
Enzyme-linked Immunosorbent Assays 
Protein extraction and quantification 
Individual embryos were homogenized on ice in microcentrifuge tubes with 50 µl 
of 1X PBS containing 1µl of protease inhibitor cocktail (P8340, Sigma-Aldrich, St. 
Louis, Missouri, USA) using an acrylic pellet pestle tissue grinder. The sample was then 
centrifuged at 800 RPM at 4˚C. Homogenates were stored at -20˚C prior to protein 
quantification and ELISA analysis. On the day the ELISAs were run, protein 
concentrations were determined using the Pierce MicroBCA protein assay kit according 
to the manufacturer’s instructions. The kit provided bovine serum albumin (BSA) 
standard solution was used to prepare a standard curve. Linear regression analysis 
(minimum R2 for the standard curve of 0.95) was used to generate standard curves (Prism 
v5, GraphPad) and embryo homogenate protein concentrations were interpolated from 
the standard curves. 
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Indirect ELISA for IGF-I  
The relative concentrations of IGF-I were determined using an indirect enzyme-
linked immunosorbent assay (ELISA) modified from (Wilkinson, Elliott et al. 2004). All 
samples and standards were run in triplicate. A 1 mg/ml stock solution of IGF-I protein 
(Salmon/Trout Insulin-like Growth Factor-I (Oncorhynchus mykiss, Gropep, Adelaide, 
Australia) was serial diluted in carbonate buffer (0.015 M Na2CO3, 0.035 M NaHCO3, 
pH 9.6) to a range of 1000 – 0.9 µg/ml. Samples were diluted to 5000 µg/ml. The wells 
of a 96 well plates (flat bottom, polystyrene, Microlon® 200, med. Binding, Greiner Bio-
one, Germany) were coated with standards or samples for 24 hr at 4˚C on a rocker with 
gentle rotation. Coating buffer was removed by pounding the microplate onto clean paper 
towels until the wells were dry. The microplate wells were then washed with 300 µl of 
wash solution (1 X PBS, 0.05% Tween-20) for 5 min on a rocker with gentle rotation at 
room temperature. Wash solution was removed by pounding the microplate onto clean 
paper towels until wells were dry. Washing was repeated 5 times. Following the washes, 
wells were incubated in 200 µl of blocking buffer (2% BSA in 1 X PBS) for 1 hr at room 
temperature. After blocking, wells were washed as described above. Wells were then 
incubated with 100 µl of IGF-I rabbit polyclonal antibody (raised against human IGF-I, 
Gropep, Adelaide, Australia, diluted 1:1000) for 1 hr at room temperature on a rocker 
with gentle rotation. The microplate wells were again washed 5 times as previously 
detailed. Wells were then incubated with 100 µl of anti-rabbit IgG antibody conjugated 
with HRP (Abcam, diluted 1:500) for 1.5 hr at room temperature on a rocker with gentle 
rotation. The microplate wells were again washed 5 times as previously detailed. ELISA 
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color development was initiated by the addition of 100 µl of 1-Step Ultra TMB-ELISA 
(Thermofisher Scientific) coloring substrate followed by a 15 min incubation at RT in the 
dark. Color development was stopped by the addition of 100 µl of 0.5 M sulfuric acid. 
Absorbance at 450 nm (A450) was measured for each well using an Infinite M200 Pro 
microplate reader (Tecan, Männedorf, Switzerland). For each sample the average of the 
three A450 values was used in subsequent calculations. Replicates were only used if they 
were within 20% of the sample mean. If a sample had less than 3 replicates within 20% 
of the mean, then the sample was re-run on a fresh plate from start to finish.  
 
Competitive ELISA for IGF-II 
Standards and samples were prepared in 1.5 ml centrifuge tubes (Natural Micro 
Centrifuge Tube, Sealrite, USA Scientific). Standard solutions of purified salmon IGF-II 
(GroPep, Adelaide, Australia) were diluted in 1X PBS containing 0.1% BSA to final 
concentrations ranging from 1000 – 0.9 µg/ml in a final volume of 400 µl. For embryo 
homogenates, 125 µg of total protein was diluted in 1X PBS containing 0.1% BSA to a 
final concentration of 5000 µg/ml in a final volume of 400 µl. Samples and standards 
were treated with acid to release IGF-II from IGF-binding proteins (IGFBP). The diluted 
standard and samples were acidified by the addition of 70 µl 0.1 M Glycine-HCl (pH 2.0) 
to each tube followed by a 30 min incubation with gentle rocking at room temperature. 
The samples/standards were neutralized by the addition of 30 µl 0.2 M Tris (pH 10.0). 
IGF-II antibody solution (200 µl of 1:1000, diluted in 1X PBS with 0.1% BSA) was 
added to each standard or sample. The IGF-II antibody was a rabbit polyclonal antibody 
34 
raised against Salmon/Trout IGF-II (Gropep, Adelaide, Australia). The standards and 
samples were then incubated with gentle rotation for 2 hr at room temperature. 
The relative concentrations of IGF- II proteins were determined using a 
competitive binding enzyme-linked immunosorbent assay (ELISA) modified from 
(Wilkinson, Elliott et al. 2004). All samples and standards were run in triplicate. A 1 
mg/ml stock solution of IGF protein (Salmon/Trout Insulin-like Growth Factor-II 
(Oncorhynchus kisutch & Oncorhynchus mykiss, Gropep, Adelaide, Australia) was 
diluted in carbonate buffer (0.015 M Na2CO3, 0.035 M NaHCO3, pH 9.6) to a final 
concentration of of 50 µg/ml. Each well of a 96 well microplate (flat bottom, polystyrene, 
Microlon® 200, med. Binding, Greiner Bio-one, Germany) was coated with 100 µl of 
IGF-II for 24 hr at 4˚C on a rocker with gentle rotation. Coating buffer was removed by 
pounding the microplate onto clean paper towels until the wells were dry. The microplate 
wells were then washed with 300 µl of wash solution (1 X PBS, 0.05% Tween-20) for 5 
min on a rocker with gentle rotation at room temperature. Wash solution was removed by 
pounding the microplate onto clean paper towels until the wells were dry. Washing was 
repeated 5 times. Following the washes, wells were incubated in 200 µl of blocking 
buffer (2% BSA in 1 X PBS) for 1 hr at room temperature. After blocking, wells were 
washed as described above. IGF-II standards or embryo homogenates were prepared as 
described above and 100 µl of each preparation was added to a well and incubated for 30 
min with gentle rocking. The microplate wells were then washed 5 times as described 
above. Wells were then incubated with 100 µl of anti-rabbit IgG antibody conjugated 
with HRP (Abcam, diluted 1:1000) for 1 hr at room temperature on a rocker with gentle 
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rotation. The microplate wells were again washed 5 times as previously detailed. ELISA 
color development was initiated by the addition of 100 µl of 1-Step Ultra TMB-ELISA 
(Thermofisher Scientific) coloring substrate followed by 15 min incubation at RT in the 
dark. Color development was stopped by the addition of 100 µl of 0.5 M sulfuric acid. 
Absorbance at 450 nm (A450) was measured for each well using an Infinite M200 Pro 
microplate reader (Tecan, Männedorf, Switzerland). For each sample the average of the 
three A450 values was used in subsequent calculations. Replicates were only used if they 
were within 20% of the sample mean. If a sample had less than 3 replicates within 20% 
of the mean, then the sample was re-run on a fresh plate from start to finish.  
Standard curves for each plate were generated using linear regression analysis. If 
the R2 value of the standard curve was less than 0.90, the whole assay was discarded. 
Amounts of IGF proteins in embryo homogenates were calculated by interpolation using 
their A450 values and the standard curve. Relative concentrations of IGFs were then 
calculated relative to the amount of IGF-I or II present in a newly fertilized embryo 
sample that was run on each plate.  
 
Statistical Analysis 
Graphical and statistical analyses of the data were performed using Prism 5.0 
software (GraphPad) and R version 3.2.1 (R Studio). Where appropriate, analysis of 
variance (ANOVA), t-tests, or linear regression analyses were used. Tukey’s honest 
significant difference (HSD) or Dunnett’s test were used for post-hoc comparisons where 
appropriate. Statistical significance was always determined at a level of P-value < 0.05. 
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Fold change was calculated by based on the either corresponding DPF or WS depending 
on what was appropriate (Mariani, Budhraja et al. 2003).  
 
Results 
Validation of the ELISA Protein Assay 
The linear range of the IGF-I and IGF-II ELISAs was determined by serial 
dilution of a random sample from the data set for each protein. Linear regression analysis 
was used to determine if changes in concentration were detected in a linear fashion. For 
both the IGF-I and –II, the serial dilutions resulted in a linear relationship between 
protein concentration and color development as illustrated in Figure 2.1. For both 
proteins an R2 value of 1.0 was calculated for the relationship between protein 
concentration and assay color development, illustrating that 100% of the variation in the 
assay signal was due to differences in the amount of IGF protein in the sample.  
 
Expression of IGF-I 
There are clear differences in the expression of IGF-I as a function of 
developmental time in embryos developing along the diapause II and escape trajectories 
(Figure 2.2). Because the two trajectories develop at very different rates, it is easier to 
compare similar developmental stages if the data are compared as a function of 
developmental stage, rather than age (Figure 2.3). When similar stage embryos are 
compared, there is a clear spike in IGF-I protein expression between WS 20 and WS 30 
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in embryos developing at 30°C along the escape trajectory. Expression increases almost 
6-fold by WS 23 (reaggregating blastomeres), remains high through WS 28 (solid neural 
keel), and then returns to levels similar to those at fertilization at WS 30 (10 somite 
embryo) (ANOVA, Dunnett’s MCT, p<0.001). Expression of IGF-I in embryos 
developing at 25°C does not increase above levels present at fertilization until after 
embryos exit diapause II at WS 40 and later (ANOVA, Dunnett’s MCT, p<0.0001). 
Thus, it is clear that embryos incubated at 30°C experience a spike in IGF-I protein 
expression early in development that is completely absent in embryos developing at 25°C 
(Figure 2.3). The pattern of IGF-I protein expression during late development (WS 32 – 
43) is also very different in the two developmental trajectories. Escape embryo (30°C) 
IGF-I levels peak at WS 37, long before growth and development are complete, and then 
decrease to levels that are indistinguishable from WS 4 embryos at WS 43. In contrast, 
post-diapause II embryos (25°C) reach peak expression of IGF-I at WS 43, essentially at 
the completion of development. These different patterns of expression are supported by 
statistical differences in mean IGF-I protein expression at numerous developmental 
stages (Figure 2.3). 
 
Expression of IGF-II 
 The pattern of IGF-II expression is quite different from that of IGF-I, for both 
developmental trajectories. First, embryos collected from females that were confirmed to 
be producing 100% escape embryos produced embryos with significantly higher levels of 
IGF-II protein at fertilization (Figure 2.3, WS 4 comparison). Second, there was a 
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significant decrease in IGF-II protein levels during early development in both 
developmental trajectories. Statistically significant increases in IGF-II protein expression 
are not observed until late embryonic development in both trajectories.  
 
Discussion 
Insulin-like growth factors are known to be critical for proper cell growth and 
differentiation during vertebrate development (Dupont and Holzenberger 2003). In 
addition, IGF’s have been shown to play a critical role in the regulation of metabolic 
dormancy associated with diapause or diapause-like states in a number of organisms (de 
Pablo, Perez-Villamil et al. 1993, Kimura, Tissenbaum et al. 1997, Richard-Parpaillon, 
Heligon et al. 2002, Eivers, McCarthy et al. 2004, Hondo and Stewart 2005, Simao, 
Camps et al. 2007, Fielenbach and Antebi 2008). This is the first study to evaluate the 
potential role of IGFs in development and diapause in embryos of the annual killifish 
Austrofundulus limnaeus. 
 Entrance into diapause II in A. limnaeus is an alternative developmental trajectory 
that can be programmed by maternal inputs and also triggered by incubation temperatures 
(Podrabsky et al., 2010). This study documents significant differences in the timing and 
magnitude of IGF protein expression in the two developmental trajectories. These 
differential expression patterns suggest a major role for IGF protein signaling in the 
promotion of the escape trajectory during early development, and in the regulation of the 
rate of embryonic growth during post-diapause II development. 
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Regulation of developmental trajectory 
 Previous studies indicate that incubation of embryos at 30°C leads to 100% of the 
embryos developing along the escape trajectory (Podrabsky et al., 2010). In addition, a 
“critical window” of developmental time in embryos between 10 and 20 somites was 
identified when temperature appears to exert irreversible effects on developmental 
trajectory. Interestingly, when embryos are incubated at 30°C, a spike of IGF-I protein is 
observed in the stages just leading up to this critical window. Thus, it is possible that 
IGF-I signaling initiates a gene expression program that favors direct development and 
prevents the embryos from entering into diapause II. This is the first evidence that 
implicates IGF signaling in the control of diapause in annual killifish. 
 Maternal provisioning or influences are known to affect the developmental 
trajectory of A. limnaeus (Podrabsky et al., 2010). The higher expression of IGF-II 
protein in 2-cell stage embryos of A. limnaeus that are presumed to be developing along 
the escape trajectory may indicate a role for IGF-II in the regulation of maternal control 
over developmental trajectory. Indeed the paternal IGF-II gene is imprinted in many 
species (DeChiara, Robertson et al. 1991, Vu and Hoffman 1994, O'Dell and Day 1998). 
Analysis of downstream targets of IGF-II signaling may help to identify these targets. 
 
Catch-up growth during post-diapause II development 
Compensatory acceleration in growth and development is a typical reaction in 
animals following release from stressed states or adverse environments that have slowed 
or arrested growth. This phenomenon is called “catch-up’ growth and is found in 
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embryos throughout the animal kingdom, and in response to a number of human diseases 
(Gillooly, Charnov et al. 2002, Hales and Ozanne 2003, Kajimura, Aida et al. 2005, 
Saenger, Czernichow et al. 2007, Fielenbach and Antebi 2008). Building off of Kajimura 
et al. (2005), Kamei (2011) shows that after hypoxia there is a “catch-up” pattern in D. 
rerio embryos whose IGF pathways where inhibited pharmacologically or by hypoxia. 
These studies confirmed that over-expression of IGF-I fueled the compensatory growth 
(Kamei, Ding et al. 2011). The broad phylogenetic representation of “catch-up” growth 
suggests that the phenomenon is likely an important and evolutionarily conserved 
mechanism with adaptive value. However, Hales and Ozanne (2003) point out that there 
are long-term consequences to this short-term fix that have potential drawbacks in 
relation to long-term survival. In rats, Rattus rattus, male longevity was reduced in 
individuals that experienced developmental retardation and subsequent “catch-up” 
growth compared to those developing along a more continuous trajectory (Hales and 
Ozanne 2003). Reproductive fitness has also been affected in some species such as 
skewed sex ratios in flesh flies destined for diapause (Denlinger 1981).  
Patterns of metabolic enzyme activity measured during post-diapause II 
development in A. limnaeus suggest “catch-up” growth is a normal part of development 
for this species. This observation is based on the rate of increase in lactate dehydrogenase 
(LDH) and citrate synthase (CS) activity in embryos developing post-diapause II at 25°C 
and those developing at 25 and 30°C along the escape trajectory. The slope of the 
increase in activity for both of these enzymes associated with post-diapause II 
development at 25°C was equivalent to the embryos developing at 30°C, suggesting an 
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acceleration in the rate that overcame the expected decrease associated with the 
differences in temperature (Chennault and Podrabsky 2010). Patterns of IGF-I and IGF-II 
expression in this study support a role for increased expression of IGFs fueling this 
compensatory acceleration in the rate of development. For example, both IGF-I and IGF-
II increase dramatically late in development in post-diapause II embryos. In contrast, 
escape embryos reach a peak in expression for both proteins much earlier in 
development. Thus, post-diapause II embryos complete development with higher levels 
of IGF-I and IGF-II. The long term consequences of this pattern are unknown, but the 
documented differences in adult physiology and reproductive fitness that are associated 
with these two developmental trajectories in other species of annual killifish suggest that 
these developmental differences in IGF expression may have profound consequences on 
the biology of these fish (Polačik, Blažek et al. 2014). 
 
Conclusions 
 This study documents for the first time the expression patterns of IGF-I and IGF-
II during development and diapause in annual killifishes. The patterns of expression 
suggest that IGF-I and IGF-II may both play distinct roles in regulating developmental 
trajectory in early embryos of A. limnaeus. In addition, patterns of IGF expression are 
vastly different during late development in these two developmental trajectories, and may 
lead to long-term differences in adult physiology and behavior. Further exploration of the 
IGF signaling pathway in this species is likely to shed light on the regulation of diapause 
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in this species, and perhaps help to elucidate the connection between diapause and 





















Figure 2.1. Absorbance is directly proportional to the concentration of IGF-I and IGF-II 
protein in the ELISA assays used for this study.  
A.) Symbols are means ± sem (n=3-5). For IGF-I, the data represent a serial dilution of a sample 
derived from 4 days post-fertilization embryos at 25˚C (R2 = 1, p<0.0001). B.) For IGF-II, the 
data represent a serial dilution of a sample derived from 2 days post-diapause II embryos at 25˚C 
(R2 = 0.99, p<0.0001). 
  



















































Figure 2.2. Relative abundance of IGF-I and IGF-II in embryos incubated at 25°C 
(diapause II trajectory) and 30°C (escape trajectory) as a function of developmental time.  
Protein levels are expressed relative to the mean of protein levels for embryos at 0 days post-
fertilization (Wourms’ Stage 4) incubated at 25°C. Symbols are means ± sem (n=3-10). 
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Figure 2.3. Relative abundance of IGF-I and IGF-II incubated at 25°C (diapause II 
trajectory) and 30°C (escape trajectory) as a function of developmental stage. 
Protein levels are expressed relative to the mean of protein levels for embryos at Wourms’ stage 
(WS) 4 (0 days post-fertilization) incubated at 25°C. Symbols are means ± sem (n=3-10). Black 
dotted lines at y=1 indicates relative expression level of WS 4 embryos. Gray vertical dashed 
lines indicate various developmental stages as indicated in the top panel. Statistical comparisons 
were made within each treatment group only using ANOVA and Dunnett’s multiple comparison 
test. Symbols with an asterisk are statistically different from levels at WS 4 for each treatment 
group (p<0.01). Pound symbols indicate statistical differences between the two developmental 
trajectories, at those developmental stages where data were available for both (two-way ANOVA, 
Sidak’s Multiple Comparison test, p<0.001). 
 








































































Chapter 3: Development of Austrofundulus limnaeus Embryos Subjected to 
Pharmacological Inhibition of Insulin-like Growth Factor Pathway  
 
Abstract 
 Many animals respond to environmental stress by slowing down or arresting 
growth and development. However, some animals, like Austrofundulus limnaeus have the 
ability to arrest development in diapause through endogenous mechanisms as a means to 
“escape in time” from unfavorable environmental conditions. Blockage of insulin-like 
growth factor signaling has been implicated in the regulation of entrance into diapause 
and diapause-like states in a number of animal groups. To determine if the IGF pathway 
plays a critical role in regulation of diapause in embryos of A. limnaeus, we inhibited the 
IGF pathway with pharmacological agents. NVP-AEW541, BMS-754807, LY294002 
and U0126 were used to inhibit the Insulin receptor/IGF1R, IGF1R, PI3K and Mek1/2 
activities, respectively. Embryos in LY294002 and U0126 were unaffected at non-lethal 
levels of inhibitors and had no significant difference in development from control 
embryos. Embryos placed in NVP-AEW541 and BMS-754807 experience reduced 
growth in both 25˚C and 30˚C, but embryos in NVP-AEW541 were able to compensate 
and catch-up in growth rapidly, and had no arrested development. Embryos treated with 
BMS-754807 experienced significant delays in morphological and physiological 
development that in many ways mimic entrance into diapause II. Activation of the IGF 
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signaling pathway appears to be part of a cohort of regulatory events that lead to active 
development in this species.  
Introduction 
The annual killifish, Austrofundulus limnaeus, inhabits the ephemeral ponds of 
Venezuela that dry on a seasonal basis. This harsh and often unpredictable environment 
has driven the evolution of embryonic development to include diapause as an adaptation 
for survival through the dry season. The ability to arrest development and endure the 
extreme stresses of this environment is not a simple pause in development, but an 
alternative developmental pathway that differs morphologically, physiologically, and 
biochemically from direct-developing “escape” embryos (Chennault and Podrabsky 
2010, Podrabsky, Garrett et al. 2010, Furness, Reznick et al. 2015) (also see Chapter 2). 
In other animal groups Insulin-like growth factor signaling appears to play a critical role 
in regulating entrance into metabolic dormancy. Here I explore the possible role of IGF 
signaling in the regulation of diapause in embryos of A. limnaeus. 
 Insulin-like growth factors (IGFs) are a group of highly conserved protein 
hormones (Bonafe, Barbieri et al. 2003) that regulate various developmental processes 
such as cell division, growth, differentiation, and migration (Jones and Clemmons 2013). 
IGF activity is mitigated through three classes of receptors: insulin receptors, insulin-like 
growth factor 1 receptors (IGF1R), and insulin-like growth factor 2 receptor (IGF2R, or 
cation-independent mannose-6-phosphate receptor) (LeRoith, Werner et al. 1995). The 
main receptor for IGF-I and IGF-II that activates the IGF signaling pathway is the 
IGF1R. Insulin receptor (IR) has a much higher affinity for insulin than it does for IGF-II 
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and IGF-I doesn’t react with IR homodimers, and thus IR is likely not physiologically 
active in terms of IGF signaling (Massague and Czech 1982, Kim and Accili 2002). 
However, there is evidence of hybrid heterodimers formed by one IR α and β subunit 
and one IGF1R α and β subunit (Kasuya, Paz et al. 1993, Soos, Field et al. 1993) and 
these hybrid IR/IGF1R complexes have a high affinity for IGF-I rather than insulin, and 
behave like IGF1R receptors rather than IR receptors (Belfiore, Pandini et al. 1999). In 
contrast to the other receptors, IGF2R is a negative regulator of the IGF pathway that is 
responsible for attenuating IGF-II signals by binding IGF-II and stimulating endocytotic 
lysosomal degradation (Griffiths, Hoflack et al. 1988, Lau, Stewart et al. 1994). 
The IGF1 receptor is activated when either IGF-I or II binds with two 
extracellular α-subunits of IGF1R. Binding of the ligand stimulates autophosphorylation 
of the IGF1R intracellular domain, which activates intracellular signaling cascades 
including the MAPK/Erk (Ras-Raf-Mek-Erk) pathway, and the PI3K/AKT/mTOR 
pathway (phosphatidylinositol-4,5-bisphosphate 3-kinase/Protein kinase B (PKB or 
AKT)/mammalian target of rapamycin) pathway (Furstenberger and Senn 2002, Kim and 
Accili 2002). The activation of these pathways results in a context dependent regulation 
of a diversity of cellular functions including metabolism, growth, proliferation, survival, 
transcription and protein synthesis (Vincent and Feldman 2002, Jones and Clemmons 
2013).  
 A number of pharmacological reagents have been developed that can inhibit the 
function of various proteins in the IGF pathway. NVP-AEW541 is one novel and potent 
inhibitor of IGF receptors, but it also has significant cross-reactivity with the insulin 
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receptor (Garcia-Echeverria, Pearson et al. 2004). BMS-754807 is another potent 
inhibitor that specifically targets IGF1R with less cross-reactivity with the insulin 
receptor (Carboni, Wittman et al. 2009, Kamei, Ding et al. 2011). Both of these inhibitors 
block receptor activity and thus will act to reduce or abolish IGF-I or II signaling through 
the IGF1R. LY294002 and U0126 are both inhibitors of signaling pathways downstream 
of the IGF1R receptor. LY294002 is a PI3K α/δ/β inhibitor, which is involved in crucial 
cellular functions such as cellular growth, proliferation, differentiation, motility, survival, 
and intracellular trafficking and is the first step in the PI3K-AKT-mTOR pathway. 
U0126 is a MEK 1/2 inhibitor, which is involved in various crucial cellular functions as 
well and is part of the link in the Ras-Raf-Mek-Erk pathway. Both of these downstream 
signals are not solely activated by IGF-I and II through the IGF pathway. The PI3K-
AKT-mTOR is also activated through prolactin (PRL) and epidermal growth factor 
(EGF) (Bjorge, Chan et al. 1990, Ratovondrahona, Fournier et al. 1998). While these 
inhibitors are likely to have more non-IGF-specific effects, they may also help to shed 
light on the signaling pathways that IGF receptors are acting through during development 
in A. limnaeus. 
Animal embryogenesis is believed to be shielded against perturbation from 
genetic and environmental stressors to ensure correct and accurate development of form 
and function. This concept of development referred to as “canalization” was first put 
forth by Waddington (Waddington 1942). Waddington stated that, “developmental 
reactions, as they occur in organisms submitted to natural selection...are adjusted so as to 
bring about one definite end-result regardless of minor variations in conditions during the 
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course of the reaction”. Canalization and developmental stability work together to define 
the temporal and spatial constraints of the developmental processes that are commonly 
observed in developing embryos (Willmore, Young et al. 2007). Canalization is thought 
to be especially important during early development and the establishment and patterning 
of the primary body axes, which has been established for over a century by Von Baer and 
his three laws (Von Baer 1828, Duboule 1995) that suggest developmental plasticity and 
heterokairy (see below) are minimized during the development of most systems (Spicer 
and Burggren 2003, West-Eberhard 2005, Gomez-Mestre and Buchholz 2006). 
Developmental plasticity comes in two forms: Developmental conversion and phenotypic 
modulation. The difference between phenotypic modulation and developmental 
conversion is that phenotypic modulation is a sliding scale that can have a variety of 
phenotypic outcomes, where conversion is a “switch” that is turned on or off (Smith-Gill 
1983). Developmental conversion states that organisms use a specific environmental cue 
to activate alternative genetic programs controlling development. A classical example is 
temperature effects on fish embryogenesis, Stockard (1921) defined the concept of 
“critical periods,” in which it was noted that teratogenic effects are not agent-specific but 
are determined by the stage of development in which exposure occurs—meaning that at 
specific stages in development different organs or tissues will be more or less sensitive to 
environmental stressors. Such differential sensitivities can then alter the relative timing of 
growth and maturation of various tissues or organs (Stockard 1921). Environmentally 
induced acceleration or retardation of development of individual parts relative to other 
parts may lead to significant phenotypic alterations (Berven, Gill et al. 1979). Alternative 
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pathways may lead to different morphologies, rates of development, and even to 
developmental arrest as illustrated in A. limnaeus (Podrabsky, Garrett et al. 2010). 
Heterokairy is defined as variability or plasticity in timing of various 
developmental events at the individual or population level (Spicer and Burggren 2003, 
Spicer and Rundle 2007). This can apply to both rates of development or the scheduling 
of developmental events. A classical example of heterokairy can be found in cultured 
brine shrimp Artemia. When Artemia are cultured under hypoxia (PO2 50% of normoxia), 
they precociously develop the adult phenotype of being oxyregulators at developmental 
stage 3 instead of the typical stage 6 (Spicer and El-Gamal 1999). Most documented 
cases of alternative phenotypes have been shown to occur late in the developmental 
sequence, and typically as rather minor alterations in morphology or physiology (Spicer 
and Burggren 2003, Gomez-Mestre and Buchholz 2006, Spicer and Rundle 2007, Storz 
and Travis 2007). In the case of A. limnaeus, two alternative developmental pathways, 
diapause II and escape, diverge early in development during formation of the primary 
embryonic axis (Podrabsky, Garrett et al. 2010). Alternative pathways are part of the 
normal developmental program in this species and can be regulated by maternal effects 
and by the incubation temperature experienced by the embryo (Podrabsky, Garrett et al. 
2010).  
 The goal of this study is to determine if pharmacological blocking of IGF 
signaling will affect the developmental phenotypes in A. limnaeus embryos. Specifically, 
I hypothesize that blocking the IGF pathway during the temperature-sensitive critical 
window for determining developmental trajectory (Podrabsky, Garrett et al. 2010) will 
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result in embryos entering diapause II even at temperatures that should induce the escape 
pathway.  
Materials and Methods 
Animal Care and Facilities 
 Animal care and facilities are identical to section in chapter 2. 
 
 
Sampling for Pharmacological Inhibition 
Embryos were spawned on February 12th and March 4th, 2016 following the same 
protocols as seen in chapter 2. After 24 hours, embryos were staged according to 
Wourms’ staging (WS) protocol (Wourms 1972) using an inverted microscope. Typical 
developmental timing for embryos developing at 25 and 30˚C are presented in Table 4.1. 
A total of 880 embryos were observed across the two spawning events in this experiment. 
For pharmacological exposures, individual embryos were incubated in wells of a 96-well 
plate that contained 300 µl of media. All embryos were observed daily for the duration of 
the experiment using an inverted compound microscope (Leica, DMIRB). 
  
Pharmacological Inhibition Protocol 
 Four inhibitors were chosen for this study: NVP-AEW541, BMS-754807, 
LY294002, and U0126 were used to inhibit the Insulin receptor/IGF1R, IGF1R, PI3K 
and Mek1/2 activities, respectively. All pharmacological inhibitors were purchased from 
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Selleck Chemicals (Houston, Texas, USA). BMS-754807 is a specific inhibitor for 
IGF1R (Bid, London et al. 2013), while NVP-AEW541 is a more general inhibitor of the 
insulin and IGF pathways. Lyophilized pharmacological agents were reconstituted in 
dimethyl sulfoxide (DMSO), as stock solutions. Stock solutions were diluted into embryo 
medium (Podrabsky 1999) without antibiotics and with a final concentration of less than 
1% DMSO. For each inhibitor, control embryos were exposed to the same amount of 
DMSO as embryos treated with the pharmacological agents. Final concentrations used in 
the experiments were: NVP-AEW541 (100, 50, 20, 10, and 5 µM); BMS-754807 (5, 4, 3, 
2.5, and 1 µM); Ly294002 (100, 50, 25, 5, and 2.5 µM); U0126 (200, 100, and 50 µM). 
These concentrations are based on similar experiments performed in Danio rerio, but 
taking into account known differences in the permeability of A. limnaeus embryos 
compared to D. rerio embryos for such compounds. Due to these known differences, the 
concentrations used here are about 10 times the effective concentration used in D. rerio 
(Brummett and Dumont 1981, Kim, Hwang et al. 2006, Kamei, Ding et al. 2011).  
 
Heart Rate Monitoring 
 Heart rate was monitored for embryos exposed to three concentrations of BMS-
754807 (2.5, 3 and 4 µM) as soon as heart contractions were visible. Heartrate is 




Graphical and statistical analyses of the data were performed using Prism 7.0 
software (GraphPad). Where appropriate, analysis of variance (ANOVA), t-tests or linear 
regression analysis were used. Tukey’s honest significant difference (HSD) or Dunnett’s 
test were used for post hoc comparisons where appropriate. Statistical significance was 
always determined at a level of P<0.05. For percentage data, the statistics were applied to 
the arcsine transformation of the proportions (Zar 1996). 
 
Results 
 Embryos incubated in low concentrations of NVP-AEW541, LY294002, and 
U0126 had developmental rates that were indistinguishable from control embryos 
incubated at 30˚C (data not shown). In contrast, medium and high dosages of these 
pharmacological agents resulted in 80-100% death. Those embryos that did survive 
exhibited severe developmental malformation. These data are interpreted to be the result 
of broad and non-specific effects caused by blocking signaling pathways that are 
indispensable for normal development and are discussed no further.  
 
Developmental progression 
 The inhibitor that is specific for IGF1R, BMS-754807, exhibited much more 
specific effects on development that were dosage-dependent. The rate at which embryos 
progress through development was significantly retarded by increasing concentrations of 
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inhibitor (Figure 3.1). Compared to embryos developing at 30˚C along the escape 
trajectory, embryos incubated in inhibitor concentrations of 2.5 µM and greater were 
delayed significantly (ANOVA, Tukey’s HSD, p < 0.01). Embryos developing in 
intermediate concentrations of inhibitor (2.5, 3 and 4 µM BMS-754807) that were 
incubated at 30˚C were indistinguishable from control embryos developing at 25˚C 
(ANOVA and Tukey’s HSD, p = 0.995, 0.9996, 0.0691, respectively). The 5 µM 
treatment group was significantly delayed compared to all other treatments, and embryos 
never progressed past the dispersed cell phases of development to establish a neural keel 
(Figure 3.1). 
 Rates of somitogenesis were significantly reduced by incubation in the IGF1R 
inhibitor. Linear regression analysis indicates that embryos developing at 30˚C in the 
presence of inhibitor had rates of somitogenesis comparable to embryos developing at 
25˚C on the diapause trajectory (Figure 3.2). 
 
Heart Rate 
 Heart rate was significantly decreased in embryos incubated at 30˚C in the 
presence of the IGF1R inhibitor BMS-754807 (Figure 3.3). In fact, for embryos 
incubated at 2.5, 3, and 4 µM BMS-754807, heart rates were similar to embryos 
incubated at 25˚C along the diapause trajectory (ANOVA and Tukey’s HSD, p-value = 




 Embryos incubated in 5 µM BMS-754807 arrested development in the dispersion 
and reaggregation phases of development. Embryos treated with 2.5, 3, and 4 µM BMS-
754807 developed a morphology very similar to those of diapause II embryos with some 
significant differences. First, melanocytes differentiate and migrate in embryos exposed 
to inhibitor, while these are never expressed until after diapause II in normal embryos. 
Second, despite the low heart rates, circulating blood cells that express hemoglobin are 
present in the embryos treated with inhibitor, while this trait does not normally develop 
until post-diapause II development. Otherwise, the general morphology and number of 
somite pairs are quite similar to those of diapause II embryos (Figure 3.4) 
   
Discussion 
 This study provides evidence that blocking of IGF signaling plays a critical role in 
the arrest of growth and differentiation observed as A. limnaeus embryos enter into 
diapause. There are striking similarities between embryos entering into diapause 
naturally, and the patterns of growth arrest and physiological development that are 
induced by treatment with a potent inhibitor of IGF1R. However, inhibition of IGF1R 
does not appear to completely mimic entrance into diapause, and it appears that some 
processes that arrest in association with diapause may continue despite blocking of the 
IGF1R. These results may be interpreted in a number of different ways, but the two main 
conclusions are: (1) blockage of IGF-I signaling was incomplete in this study due to 
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continued IGF-I signaling through the IR/IGF-I heterodimers, and (2) IGF signaling is a 
critical regulator of cell growth and proliferation that is blocked in embryos that enter 
diapause, but it is not the ultimate signaling mechanism that induces the diapause or 
escape programs. Both of these explanations have merit and will be evaluated below. 
 
The IGF1R inhibited phenotype 
Treatment with BMS-754807 caused a significant delay in a number of 
developmental and physiological processes that approximate the diapause trajectory even 
under environmental conditions that should promote developmental along the escape 
trajectory. First, the pattern of heart development and physiological activity were almost 
indistinguishable from embryos developing along the diapause trajectory. However, one 
apparent difference is the appearance of pigment (presumably the expression of 
hemoglobin) in the circulating precursors of red blood cells. This is a trait that normally 
does not develop until after embryos have exited from diapause II. IGF-I and –II have 
been shown to affect the developing cardiovascular system in many different ways. 
However, there is no support for IGF signaling regulating the timing of hemoglobin 
expression in other developing fishes. In Danio rerio, IGF signaling is crucial for normal 
cardiac and circulatory development. Wood et al (2004) found that embryos with 
inhibited and reduced IGFBP-2, which increases the half-life of IGFs and has been shown 
to mediate binding of IGF1R (Shen and Singh 2004), had reduced amounts of IGF-I 
mRNA, reduced body growth, and disruptions to cardiovascular development (Wood, 
Schlueter et al. 2005). More recently, Li et al (2011) found that IGF-II expression was 
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crucial for supporting increased cellular proliferation through activation of the Ras-Raf-
Mek-Erk pathway or simply MAPK/Erk pathway in primary mouse embryonic epicardial 
cells (Li, Cavallero et al. 2011). The data presented in this chapter are consistent with 
what is known about the effects of IGF signaling on cardiovascular development in 
fishes, and since hemoglobin expression was not blocked in these experiments, it is 
reasonable to conclude that other signaling pathways must be involved in the arrest of 
development associated with diapause II that are independent of IGF signaling. 
Another major difference between normal entrance into diapause II and the 
phenotype of IGF1R embryos is the differentiation and migration of neural crest cells. In 
normal embryos, melanocytes are not observed in embryos until several days post-
diapause II. Melanocytes are derived from neural crest cells that migrate away from the 
developing neural tube and differentiate into a variety of embryonic structures – many or 
perhaps all of which are critical features of the vertebrate body plan. IGF-II is one of the 
signals that can rapidly induce neural crest cells to transition from epithelium to 
mesenchyme (the first step in migrating away from the neural tube) through changes in 
cell adhesion activated by degradation of E-cadherin (Morali, Delmas et al. 2001). Later 
in development, expression of E- and ß-cadherins increases in neural crest cells as they 
differentiate into melanoblasts – the precursors for melanocytes (Nishimura, Yoshida et 
al. 1999). Thus, there is reason to believe that IGF signaling may have an effect on 
melanocyte development. Data presented here indicate that delay of somitogenesis and 
cardiac development are much more sensitive to inhibition of IGF signaling when 
compared to melanocyte development because those processes were significantly 
59 
inhibited at much lower levels of inhibitor. However, at the highest level of inhibitor that 
still allowed embryos to develop past the dispersion and reaggregation phases, 
melanocyte development was not observed. This suggests that there may be some 
threshold of IGF signaling activity required to induce neural crest migration and/or 
melanocyte differentiation (Erickson and Goins 1995).  
 The rate of somitogenesis appears to be very sensitive to the strength of IGF 
signaling in embryos of A. limnaeus. Somitogenesis is a highly regulated patterning of 
paraxial (somatic) mesoderm next to the developing neural tube. Once initiated, this 
process proceeds according to a highly stereotyped addition of somite pairs in an anterior 
to posterior pattern. The highly similar pattern and rate of somite development in 
embryos treated with IGF1R inhibitors suggests that this process is likely regulated by 
IGF signaling. Thus, these data suggest that regulation of somatic growth and 
differentiation associated with entrance into diapause II may very well be controlled by 
inhibition of IGF signaling. This is certainly consistent with the patterns of IGF 




 These data highly support a major role for IGF signaling, and specifically the 
blockage of IGF-I protein expression in mediating the growth arrest associated with 
diapause II in embryos of A. limnaeus. To better understand the relationship between IGF 
signaling and entrance into diapause, we must next investigate the mechanisms that 
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regulate IGF-I and –II expression in developing embryos. The next logical step is to 
investigate the expression and signaling capabilities for growth hormone (GH) during 
development, as GH is a known and potent stimulator of IGF-I protein expression 
(Davey, Xie et al. 2001, Herrington 2001). Expression and activity of the hormone 
insulin may also help to inform these studies because insulin can induce many of the 
same physiological effects of IGFs, and insulin is known to regulate expression of 
IGFBPs (Cotterill, Holly et al. 1993). Further, key regulators of IGF signaling such as 
IGFBPs must be evaluated to explore physiological regulation of this pathway throughout 
development. IGFBPs sequester and inactivate IGF-I and –II, but they also increase the 
half-life of IGFs drastically, which can alter the timing and strength of their action. 
Further exploration of IGF signaling and its role in the regulation of diapause will likely 
lead to a better understanding of how growth and differentiation are regulated during 
vertebrate development, and how these pathways can be manipulated to induce reversible 
arrest of development.   
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Table 3.1. Time of Development for Austrofundulus limnaeus at 25˚C and 30˚C 
Wourm's Stage Developmental Description 25˚C Timing 30˚C Timing 
1 Unfertilized egg 0 HPF 0 HPF 
2 Activated egg - - 
3 One cell stage 1 HPF - 
4 Two cell stage 2 HPF - 
5 Four cell stage 3 HPF - 
6 Eight cell stage 4 HPF - 
7 Sixteen cell stage 5 HPF - 
8 Thirty-two cell stage 6 HPF - 
9 Sixty-four cell stage 7 HPF - 
10 High solid blastula 24 HPF 1 DPF 
11 Flat solid blastula 36 HPF - 
12 Early flat hollow blastula 40 HPF - 
13 Late flat hollow blastula - - 
14 Expanding flat hollow blastula 2 DPF - 
15 Early epiboly 2 DPF - 
16 One-fourth epiboly 2 DPF - 
17 One-half epiboly 2.25 DPF - 
18 Three-fourths epiboly 2.5 DPF 2 DPF 
19 Completion of epiboly 3 DPF 2.5 DPF 
20 Dispersed phase 1 4-6 DPF 3 DPF 
21 Dispersed phase 2 4-6 DPF 4.5 DPF 
22 Reaggregation 1 6-10 DPF 5 DPF 
23 Reaggregation 2 6-10 DPF - 
24 Reaggregation 3 6-10 DPF - 
25 Reaggregation 4 6-10 DPF - 
26 Reaggregation 5 6-10 DPF 6 DPF 
27 Definitive axis - 6.5
28 Solid neural keel 10 DPF 7 DPF 
29 Early somite embryo 11 DPF 8 DPF 
30 Ten somite embryo 14 DPF 9 DPF 
31 Twenty-five somite embryo 19 DPF 10 DPF 
32 Diapause II - 38 somite pairs 24 DPF - 
33 Post diapause II - 1 1 DPD - 
34 Post diapause II - 2 1 DPD - 
35 Post diapause II - 3 gut formation 2 DPD - 
36 One-half overgrowth - no eye pigments 4 DPD 11 DPF 
37 Eye pigments, tail bud free 6 DPD 12 DPF 
38 Reflecting material in eye, gall bladder - 13 DPF 
39 Three-fourths overgrowth 9 DPD 16 DPF 
40 Full overgrowth 12 DPD 17 DPF 
41 Early pre-hatching - 18 DPF
42 Mid pre-hatching - 20 DPF
43 Late pre-hatching - diapause III 24 DPD 24 - 32 DPF 
44 Hatching 24 DPD + 33 DPF + 
45 Yolk absorbed - - 
46 Larva - - 
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Figure 3.1. Development of embryos at 30˚C exposed to a range of concentrations of the 
IGF1R inhibitor BMS-754807.  
Increasing concentrations of the inhibitor significantly retards rate of development. At inhibitor 
levels of 2.5, 3, and 4 µM, developmental progression in embryos at 30˚C indistinguishable from 
those developing at 25˚C (ANOVA and Tukey’s HSD, p-value = 0.995, 0.9996, 0.0691, 
respectively). Symbols are means ± sem (n = 10). 





























Figure 3.2. Rates of somitogenesis in embryos incubated at 30˚C and treated with the 
IGF1R Inhibitor BMS-754807.  
Linear regression analysis indicates that embryos treated with inhibitor and incubated at 30˚C had 
rates of somitogenesis that were comparable to embryos incubated at 25˚C (t-test, p < 0.0001). 
Data for the DMSO controls and 30˚C escape embryos were combined, because regression 
analysis indicated no significant differences (t-test, p = 0.9915). Symbols are means ± sem (n = 5-
13). 
  





























Figure 3.3. Heart rate in embryos incubated at 30˚C in the presence of the IGF1R inhibitor 
BMS-754807.  
Treated embryos had heart rates comparable to embryos developing at 25˚C along the diapause 
trajectory. (ANOVA and Tukey’s HSD, p = 0.2764, 0.9882, and 0.9998, respectively). Control 
embryos incubated at 30˚C have heart rates significantly higher than all other treatments 
(ANOVA, p-value < 0.0001, Tukey’s HSD p < 0.0001). Symbols are means ± sem (n = 1-10). 






























Figure 3.4. Images of embryos incubated at 30˚C and treated with the IGF1R inhibitor 
BMS-754807.  
Embryos were observed over 32 days post-treatment (dpt). All groups were initially exposed to 
inhibitor at WS 10-12 at 1 day post-fertilization and were continuously exposed for the duration 
of development. Embryos incubated at 2.5, 3, and 4 µM inhibitor developed in a manner very 





















Chapter 4: Profiling of mRNA Transcript Expression for Genes Involved in the 
Insulin-like Growth Factor Pathway in embryos of Austrofundulus limnaeus 
developing along the diapause and escape developmental trajectories 
Abstract 
The insulin-like growth factor (IGF) pathway is a crucial regulator of growth, 
proliferation, and differentiation in most cells. The biological actions of IGFs are 
mediated by the plasma membrane receptors that bind to an IGF and induce intracellular 
signaling cascades. IGF signaling ultimately leads to increases in cellular proliferation, 
differentiation, rates of protein synthesis, metabolism, and suppression of apoptosis. 
There are numerous genes responsible for receiving and transducing an IGF signal. 
RNAseq techniques were used to profile the expression of genes involved in known IGF 
signaling pathways in embryos of the annual killifish Austrofundulus limnaeus 
developing along two different developmental trajectories. Developmental trajectory was 
controlled by incubation temperature, with 20ºC incubation leading to diapausing 
embryos, and 30ºC incubation leading to embryos that escape dormancy in diapause. 
RNAseq analysis reveals differential expression of several key regulators of IGF activity, 




Entrance into diapause in embryos of Austrofundulus limnaeus is part of an 
alternative developmental trajectory that appears to be regulated by differential 
expression of insulin-like growth factors early in development (see Chapters 2 and 3). 
Large-scale studies that explore gene expression in developing and diapausing embryos 
of A. limnaeus can provide important insight into the global relationship that exists 
between transcription, development, and diapause. Here I explore differential gene 
expression of signaling pathways known to be involved in IGF signaling in vertebrates in 
embryos developing along the two alternative developmental trajectories. 
Suppression of growth is an important characteristic of diapause in various 
animals, including mammals, insects, nematodes, and fish (Bodenheimer and Shulov 
1951, Carter and Wourms 1993, Antebi, Yeh et al. 2000, Denlinger 2002, Fordham, 
Georges et al. 2006, Furness 2015). The IGF/FOXO pathways are critical in the 
regulation of entrance into the dauer stage in Caenorhabditis elegans; Dauer dormancy is 
a state of arrested development found in C. elegans analogous to diapause (Kimura, 
Tissenbaum et al. 1997, Lin, Hsin et al. 2001). In C. elegans, the pathway for growth and 
dormancy involves DAF-2 and DAF-16, the cognates of vertebrate IGF 1 Receptor 
(IGF1R) and FOXOs, respectively (van Heemst 2010). Additionally, in Drosophila 
melanogaster it was found that transcripts for modulation of the IGF/FOXO pathway was 
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part of entrance into diapause (Baker and Russell 2009). D. melanogaster showed 
suppression of insulin and its receptor in diapause eggs. A picture is emerging that paints 
a reduction in TOR activity and an increase in FOXO as more generalized characteristics 
of diapause across invertebrate species (Sim and Denlinger 2008, Sim, Kang et al. 2015). 
However, very little is known about how these pathways act in vertebrate diapause.  
Here I surveyed the mRNA transcriptome for genes involved in IGF signaling during the 
critical window in A. limnaeus development where incubation temperature is known to 
affect developmental trajectory. Using the Kyoto Encyclopedia of Genes and Genomes’s 
Pathway Database as a guide, I extract expression data for all IGF signaling-related genes 
from the transcriptome (Table 4.1). Exploring the differences in the timing of gene 
expression between these two pathways may lead us to understand what regulatory 
elements help define the escape and diapause developmental trajectories in A. limnaeus.  
Methods and Materials 
Animal Care and Facilities 
Animal care and facilities are identical to section in chapter 2. 
Sampling for Sequencing 
Groups of twenty 1-2 cell stage embryos from 6 different females known to 
produce exclusively diapausing or escape embryos (see Methods for Chapter 2) were 
selected and flash-frozen in liquid nitrogen. For the rest of the time points, the total 
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spawning output from 42 females were pooled and incubated at 25˚C until they reached 
mid-epiboly. At this point pooled embryos were split into two groups and placed into 
incubators at either 20 or 30˚C. Temperature was maintained in each group by placing the 
embryos in 100 x 15 mm Petri dishes into temperature-controlled incubators. Embryo 
media was changed daily. Embryos were sampled at specific developmental time points 
from both temperature treatments: 100% epiboly (WS 19), neural keel (WS 28), 6 
somites (WS 29), 10 somites (WS 30), 16 somites (WS 30.1), 20 somites (31) and 24 
somites (WS 31.1). Embryos were sampled as above with 20 embryos making up a single 
replicate.  
RNA Extraction 
Groups of embryos were weighed, and immediately homogenized in Trizol 
reagent at a ratio of 50 mg of embryo tissue to 1 ml of Trizol reagent. Homogenates were 
incubated at room temperature (RT) for 15 min. to ensure dissociation of nucleoprotein 
complexes and then subjected to centrifugation at 10,000 x g for 30 min at 8˚C to pellet 
insoluble material. The supernatant was decanted into a clean 2 ml centrifuge tube and 
0.2 ml of chloroform was added per 1 ml of Trizol reagent used for homogenization. The 
sample tubes were inverted 15 times gently for 30 seconds to mix the organic and 
aqueous phases. The solution was then spun at 10,000 x g for 20 min at 8˚C to separate 
the organic and aqueous phases. The aqueous phase (top, clear phase) was removed and 
transferred to a new 2 ml centrifuge tube and the RNA precipitated by addition of 0.25 ml 
of high salt solution (0.8 M sodium citrate and 1.2 M NaCl) and 0.25 ml of 100% 
70 
isopropanol per ml of Trizol reagent used. RNA was allowed to precipitate at -20˚C 
overnight. The samples were then spun at 10,000 x g for 30 min at 4˚C to pellet the RNA. 
The supernatant was decanted and discarded without disrupting the RNA pellet. The 
pellet was washed three times by vortexing with 2 ml of 60% ethanol followed each time 
by centrifugation at 10,000 x g for 30 min at 8˚C to pellet the RNA. The RNA pellet was 
air dried in a chemical fume hood for 5-10 min to remove any remaining ethanol. The 
RNA was resuspended in 50 µl of 1 mM sodium citrate, pH 6.4. Samples were stored at -
80˚C.  
cDNA library preparation and mRNA sequencing 
Sequencing cDNA libraries were prepared with 1 µg of total RNA using the 
Illumina TruSeq RNA Sample Preparation v2 kit according to the manufacturer’s 
instructions. The purified cDNA libraries were screened for quality on an Agilent 
Bioanalyzer 2100 using a DNA 1000 chip and quantified by RT-PCR prior to 
sequencing. DNA sequences were obtained through sequence-by-synthesis technology on 
an Illumina HiSeq 2000 (San Diego, CA) at the Oregon Health and Sciences University 
Massively Parallel Sequencing Core. 
Analysis of mRNA sequence data 
RNA sequence reads were analyzed using in house computational support and 
resources. All reads were initially characterized by FastQC to determine read length and 
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quality. Sequenced reads were filtered on quality scores and trimmed for the presence of 
adapter sequences using Trimmomatic (Bolger, Scossa et al. 2014). Quality sequence 
reads were then mapped to the A. limnaeus genome 1.0 using Bowtie2. Only aligned 
reads were used for further gene-level expression analysis. Gene counts were generated 
for all samples using the summarize Overlaps function of the Genomic Alignments 
package in Bioconductor that quantifies the number of reads per gene feature based on 
the A. limnaeus Genome Annotation (v100) available in GenBank 
(http://www.ncbi.nlm.nih.gov/genome/annotation_euk/Austrofundulus_limnaeus/100/). 
Count matrices were filtered for genes with counts of 1 or more (normalized to library 
size) summed across all biological replicates to improve computational performance and 
reduce the data for subsequent expression analysis. Expression analysis was performed 
using the Bioconductor package, DESeq2, which determines differential expression of 
sequence count data based on the negative binomial distribution. Expression of a gene 
was calculated as the number of reads per kilobase of exon model per million mapped 
reads (FPKM). Differential expression was determined for genes between diapause and 
escape conditions within each developmental stage with a threshold of significance set at 
p < 0.001 and adjusting for multiple comparisons using the Benjamini-Hochberg method 
for false discovery rate (FDR). 
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Results 
Overall patterns of expression 
The A. limnaeus genome contains 26,712 genes and pseudogenes. The 26,712 
genes are comprised of 23,844 protein-coding, 2,313 non-coding, and 55 pseudogenes. 
Of these genes 6,136 were found to have variants. A total of 24,334 mRNA transcripts 
were identified in the transcriptomes of A. limnaeus embryos used in this study. Of those 
24,334 transcripts, 20,713-24,268 transcripts were identified in various developmental 
stages as summarized in Figure 4.1. About 43% of these transcripts are expressed in each 
stage at a threshold of 2 FPKM or greater. Of these transcripts between 420-472 
(depending on stage) were identified as being involved in the IGF signaling pathway. Of 
these transcripts, between 0 and 53 were found to be differentially expressed when stage-
specific comparisons were performed between the diapause and escape trajectories at an 
FDR-adjusted p-value of 0.001 (Figure 4.1). There is a clear pattern of increasing number 
of differentially expressed genes in later developmental stages. 
IGF-I and IGF-II transcripts 
IGF-I and IGF-II transcripts are not present in 1-2 cell stage embryos, and 
therefore are not maternally packaged in A. limnaeus based on the expression threshold of 
2 FPKM set for this study (Figure 4.2). However, transcripts for IGF-I and IGF-II are 
expressed above the 2 FPKM threshold at all subsequent stages in both trajectories. IGF-
II transcripts were not found to be differentially expressed in the stages sampled for this 
73 
study. In contrast, transcripts for IGF-I were significantly upregulated (4-fold) at neural 
keel stage of development in escape embryos (two-tailed T-test, FDR 0.001, p-value < 
0.001). This spike in expression at neural keel stage in escape embryos is based on an 
average expression level of 58.58 ± 1.39 FPKM (mean ± s.e.m., n=3) (Figure 4.2). IGF-I 
transcripts were found to be 8-fold upregulated in 24-somite embryos developing along 
the diapause trajectory with an average FPKM of 23.13 ± 1.36 mean ± s.e.m., n=3) 
(Figure 4.2). Thus, this apparent increase in expression at this stage is not due to an 
increase in expression in embryos along the diapause trajectory, but rather due to 
relatively stable expression in the diapause-bound embryos and a major decrease in 
expression in the escape embryos.  
IGF receptor transcripts 
Transcripts for the IGF1R, IGF2R, and IR are all present in 1-2 cell stage 
embryos and are likely of maternal origin (Figure 4.3). IGF2R expression levels are high 
(around 12 FPKM) at fertilization and initially decrease, followed by a spike in 
expression (12-14 FPKM) at the 6 somite stage in both developmental trajectories. For 
both developmental trajectories, the highest expression of IGF1R is observed in 1-2 cell 
stage embryos and then decreases to relatively low and stable values until the 16 somite 
stage when levels increased again. IR transcript levels begin low in fertilized embryos 
(just above 2 FPKM) and steadily increased during development in both developmental 
trajectories. 
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IGF binding protein transcripts 
 Transcript levels for IGF binding proteins (IGFBP) are presented in Figure 4.4. 
There are clear developmental patterns of expression for IGFBPs that are independent of 
incubation temperature and developmental trajectory. However, there are some patterns 
of expression that suggest a role for IGFBPs in regulating IGF signaling. Transcripts for 
IGFBP2 are significantly upregulated (about 8-fold) in escape embryos starting at the 16 
somite stage (Two Tailed T-test, FDR 0.001, p-value < 0.001). While transcripts for 
many other IGFBPs were identified, no others were significantly differentially expressed 
at the stringent threshold set for this study. For example, IGFBP4 transcripts are nearing 
statistically different upregulation in 24 somite embryos on the diapause trajectory (Two 
Tailed T-test, FDR 0.001, p-value =0.040) with about a 3-fold increase (Figure 4.4). 
 
Growth hormone and GH receptor transcripts 
 Both growth hormone (GH) and GH receptor (GHR) are expressed (>6 FPKM) in 
1-2 cell stage embryos, and thus there is at least some level of maternal packaging 
(Figure 4.5). GH transcript levels increase substantially between fertilization and the 
completion of epiboly and then remain relatively stable in subsequent stages of 
development. In contrast, GHR drops drastically (Escape 68% and Diapause 72%), from 
highs near 80 FPKM in 1-2 cell stage embryos to relatively stable levels in later 
developmental stages between 12-32 FPKM (Figure 4.5). Both the diapause and escape 
trajectories have similar expression patterns during development. 
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IGF signaling pathways 
There are a number of canonical intracellular signaling pathways that are known 
to be activated through IGF and GH receptors. Differential expression analysis of genes 
known to be involved in these signaling pathways reveals several interesting patterns of 
expression in both developmental trajectories. For embryos developing along the escape 
trajectory, differential expression was first observed in embryos at completion of epiboly 
with an upregulation of a RAS-related protein, indicating a potential upregulation of the 
RAS-MAPK-ERK pathway (Figure 4.6). In subsequent developmental stages, even more 
genes involved in this pathway are upregulated, including two histone deacetylases in the 
neural keel stage and the immediate early genes Jun-B-like and c-Fos-like in 6 -16 somite 
embryos, directly in the critical window when temperature is known to affect 
developmental trajectory. Transcripts for IGF-I are significantly upregulated in the neural 
keel stage, and a known positive regulator of IGF-I activity, IGFBP2 is upregulated 
starting at the 16 somite stage. The AKT pathway is not transcriptionally upregulated 
until the 16 somite stage and later in escape trajectory embryos. For embryos developing 
along the diapause trajectory, the transcripts involved in RAS-MAPK-ERK signaling 
were also the first to be upregulated. However, a transcript important for regulation of the 
AMPK pathway is also activated early (neural keel stage) and during the critical window 
of development where temperature exerts its effects on developmental trajectory. Late in 
the developmental progression, transcripts associated with AKT signaling are 
upregulated, as are two STAT proteins and finally the transcript for IGF-I. The 
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upregulation of these transcripts as developmental rate is decreasing and embryos are 
preparing to arrest in diapause II appears paradoxical. 
Discussion 
General Caveats to the Following Discussion 
Before beginning a discussion of the gene expression patterns detailed in this 
thesis, it is critical to point out that these data, and all the data presented in this Thesis, 
are derived from whole embryos. This level of analysis is powerful because it provides a 
global picture of what may be happening in the embryo across tissues. However, it is also 
a severe limitation because spatial and tissue-specific patterns of expression remain 
unknown. Thus, it is important to point out that what appear to be very small levels of 
expression in whole embryos, could represent a massive amount of expression in a small 
number of cells or an individual tissue. In addition, a similar level of expression in the 
two trajectories cannot be equated with equivalent potency of action because the exact 
location and context of expression are as critical, perhaps even more critical, in 
determining the outcome of gene expression or cell signaling. Thus, much of the 
discussion below must be viewed with a great deal of caution. However, these gene 
expression data are useful and will certainly inform future studies on the regulation of 
diapause in this species. 
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Insulin-like Growth Factor Transcript Expression 
There is a consistent pattern between IGF-I mRNA transcript levels reported in 
this Chapter and IGF-I protein levels presented in Chapter 2 (Figure 2.3). This spike in 
IGF-I gene expression that results in increase protein expression suggests a role for IGF-I 
in regulating the increases in developmental rate and progression that are observed in 
embryos developing along the escape trajectory. However, it appears that this expression 
is not solely linked to increased rates of growth or cellular proliferation because this spike 
in expression is seen far in advance of the most rapid periods of growth and development 
associated with the escape trajectory. In fact, the spike occurs in embryos that are 
otherwise morphologically and physiologically indistinguishable from diapause-bound 
embryos. The high levels reached may represent a threshold of IGF-I expression that 
must be achieved in order to move past a critical point in development that supports 
continuous development. This pattern suggests a role for IGF-I in regulating the program 
that bypasses diapause II, and not just growth or metabolic rate. Following this same line 
of reasoning, it is also possible that the levels of IGF-I observed in the diapause-bound 
embryos never reach a critical threshold that activates the escape trajectory. If a critical 
threshold exists for IGF-I expression, it is likely highly influenced by the expression and 
activity of the IGFBPs. In this model we would expect the critical threshold to be met 
when the IGF-I levels oversaturate the binding and storage capacity of the IGFBPs 
(Baxter 2000). This threshold model would be similar to the counteracting activities of 
juvenile hormone (JH) and diapause hormone (DH) in insect diapause (LINGER and L 
2013). In silkmoths, JH acts as an antagonist to DH, and high JH/DH ratios lead to the 
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non-diapause developmental program (Morohoshi 1959). Alternatively, the pattern of 
IGF-I expression reported here for A. limnaeus could be a temporal issue, where the 
signal of IGF-I must occur at a specific time in development. For example, in C. elegans, 
IGF signaling is age- and developmental stage-dependent with specific windows of 
increased IGF sensitivity (Dillin, Crawford et al. 2002). In mammals, there is a strong 
temporal component to IGF-I signaling during brain development achieved through a 
complex interaction of IGF-I expression and the expression levels of various inhibitory 
and stimulatory IGFBPs (Walter, Berry et al. 1997). While the complex nature of the 
regulation of IGF signaling makes it difficult to draw clear conclusions from this study, it 
is clear that future investigations of IGF-I signaling are warranted and likely to yield 
interesting insights into the regulation of diapause in A. limnaeus. 
After the early peak in IGF-I expression in escape embryos, there is a rather 
dramatic drop of IGF-I protein and transcript levels. This drop eventually leads to an 
apparent upregulation of IGF-I transcripts in diapause-bound embryos. Interestingly, 
there is also an associated increase in IGF-I protein levels in diapause II embryos (Figure 
2.3). This same pattern is observed in a number of transcripts for signaling proteins that 
lead to increases in rates of cellular growth and proliferation (Figure 4.6). While this 
pattern may seem counter-intuitive, one possible explanation is that the diapause-bound 
embryos are initiating a gene expression program during pre-diapause II development 
that is needed to support post-diapause II development. This hypothesis is based on the 
fact that protein synthesis is known to be arrested in diapausing embryos of A. limnaeus 
(Podrabsky and Hand 2000) and it is common in dormant animals for rates of 
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transcription to be severely attenuated as well (Storey and Storey 1990, Guppy, Fuery et 
al. 1994, Kwast and Hand 1996). Thus, it may be critical for embryos to prepare for the 
early events of post-diapause II development, and stress tolerance during diapause, prior 
to entry into diapause. A more detailed look at the entire transcriptomes of these two 
developmental trajectories, and profiling of gene expression during exit from diapause II 
may help to shed light on this hypothesis.  
 
IGF Receptor Transcript Expression Patterns 
 In general, the expression of transcripts that code for the three main IGF receptors 
exhibit similar expression patterns in both developmental trajectories. Thus, it appears 
that changes in IGF signaling that may be associated with regulation of developmental 
trajectory are likely due to variations in the IGF proteins and their associated IGFBPs, 
rather than a lack of receptor expression. While these patterns may not be trajectory-
specific, they may shed light on when various IGF and insulin signals are likely to be 
important during development. Transcript levels for IGF1R have the highest expression 
level of all the receptors. Further, their peak in expression is observed just after 
fertilization, suggesting high levels of maternal provisioning. Transcript levels for IGF1R 
then fall dramatically by the completion of epiboly and remain low for the duration of 
early development. This pattern of expression suggests an important role for IGF1R 
during early development, and we would predict a large increase in IGF1R protein 
expression to occur by the completion of epiboly. Interestingly, this would prime the 
embryonic cells to receive the spike in IGF-I protein that is observed starting at the 
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completion of epiboly. Thus, while we do not have data on IGF1R protein expression at 
this time, these transcript data are consistent with the production of cells that are IGF-I 
competent prior to the peak in IGF-I protein observed.  
The second most abundant receptor was IGF2R, a receptor that is responsible for 
specifically reducing the signaling activity of IGF-II (Nissley, Kiess et al. 1991). Indeed, 
levels of IGF-II are low in early embryos of A. limnaeus and do not increase significantly 
until post-diapause II developmental stages. Also of interest is the large spike in IGF2R 
transcripts observed in the 6-somite stage embryos. While the exact nature of this spike is 
not understood, it appears to be important developmentally because it is observed in both 
developmental trajectories. Blocking the action of IGF-II may be an important part of the 
early development in this species and may help to explain the relatively slow rates of 
development in pre-diapause II embryos of A. limnaeus, and all annual killifish, 
compared to other species with similar sized embryos. 
At fertilization the insulin receptor (IR) has low, but clearly detectable expression 
levels. This level of maternal provisioning suggests an important role for insulin 
signaling or IGF signaling through the IR receptor during early development. At this 
point insulin levels during early development have not been determined in embryos of A. 
limnaeus, but these data suggest this may be an important hormone to explore.  
 
Insulin-like Growth Factor Binding Proteins (IGFBPs) Transcripts 
There are many steps at which IGF activity is post-translationally regulated. 
IGFBPs are extracellular proteins with high affinities for IGFs and that readily bind to 
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free IGFs in the blood and extracellular fluids. IGFBPs have a two-pronged effect on IGF 
activity: IGF signaling activity is reduced when bound to most IGFBPs, but half-life is 
increased through protection from proteases (Baxter 2000). In human males, the half-life 
of free IGF-I or -II is only about 10-12 minutes, while bound IGFs may be stable for 
days. There are numerous IGF binding proteins (IGFBPs 1-7) that can attenuate or 
accentuate IGF activity and potency. There are 7 characterized IGFBPs, and each of these 
may be expressed as several variants with unique affinities for IGF-I and –II, and in many 
cases the affinity can be altered by various environmental factors. For example, a 
reduction in pH from 7.2 – 6.0 causes an increase in the affinity of IGFBP-1 and -3, but a 
4 fold decrease in affinity to IGFBP-2 (Clemmons 1991).  
IGFBP-2 has been implicated in the regulation of IGF activity in most 
mammalian tissues and organs (Park, Kim et al. 2015), and is known to be upregulated in 
oncogenic tissues along with IGF-I or –II (Catsburg, Gunter et al. 2015, Myers, Lin et al. 
2015). IGFBP2 is also thought to play an important role in the differentiation of human 
corneal fibroblasts (Park, Kim et al. 2015), and cell mobility as observed in human lung 
cancer metastasis (Hu, Huang et al. 2014). This increase in IGF signaling that appears to 
be stimulated by IGFBP-2 is potentially due to a unique effect on the action of IGF1R 
mediated through the heparin binding domain (HBD) motif on IGFBP-2, as has been 
illustrated in vascular smooth muscle cells (Shen, Xi et al. 2012). If the large increase in 
transcripts for IGFBP-2 that is observed in escape embryos translates to increased 
excretion of this protein, then it would be expected to increase the activity of IGF 
signaling in embryos developing along the escape trajectory. 
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While IGFBP-2 can have positive effects on IGF signaling, it is very unique and 
the other IGFBPs that have been studied appear to reduce signaling activity. For example, 
IGFBP-4, which was nearly significantly upregulated in diapause-bound embryos, is a 
strong negative regulator of growth, differentiation, and mobility. Transgenic mice that 
over express IGFBP-4 have reduced organ sizes (Schneider, Lahm et al. 2000, Durai, 
Davies et al. 2006). Additionally, over expression of IGFBP-4 has a strong inhibitory 
effect on the growth of colon and prostate cancer cells (Shen and Singh 2004, Durai, 
Davies et al. 2006). Thus, increased expression of IGFBP-4 in diapause-bound embryos 
may further reinforce a reduction in IGF signaling activity that would be expected based 
on the relatively low level of observed protein expression.  
 
Growth Hormone and Growth Hormone Receptor Transcripts 
 Interestingly, GHR transcripts are expressed at the highest levels just after 
fertilization. Again, this level of maternal provisioning may indicate a key role for GHR 
in early developmental events, and may be interpreted as a need for GHR activity before 
or shortly after the activation of the zygotic genome. The pattern of GH transcript 
expression is opposite of that observed for GHR. This may be due to the relatively short 
half-life of GH (under 45 min in humans) and a need for continued GH signaling to fuel 
rapid cell growth and proliferation associated with development (Faria, Veldhuis et al. 
1989, Mullis, Rani Pal et al. 1992). In contrast, GHR likely has a much longer half-life, 
as is often the case for membrane-bound receptors (Reed and Lane 1980, K, MJ et al. 
1998). Of interest to this study is the presence of both necessary components of GH 
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signaling, GH and GHR transcripts preceding the expression of transcripts for IGFs, 
which may mean that IGFs are regulated during early development as they are in 
canonical GH-IGF axis (Davey, Xie et al. 2001, Salvatori 2004, Reinecke, Bjornsson et 
al. 2005). 
  
Expression of Transcripts for IGF Related Signaling Pathways  
 Taking a more systems or pathway-level approach may lend strength to some of 
the conclusions that have been reached in this thesis, and may also highlight possible 
signaling pathways through which IGF signals act to alter or affect developmental rate or 
trajectory. Only a small handful of transcripts associated with IGF signal transduction 
were found to be differentially expressed in the two developmental trajectories. Based on 
the upregulation of transcripts for genes in the RAS-MAPK-ERK pathway, including the 
immediate early genes, Jun-B-like and c-Fos-like, and two histone deacetylases, it is 
probable that the early effects of IGF signaling in the escape pathway are mediated 
though the RAS-MAPK-ERK pathway and the associated AP-1 transcriptional activation 
complex. It is especially interesting that the Jun-B/c-Fos-like proteins are upregulated 
during the window of development where temperature is known to have its effects on 
developmental trajectory (6-16 somite embryos) (Wagner 2002, Murphy, MacKeigan et 
al. 2003, Eckert, Adhikary et al. 2013). This, coupled with the early increase in IGF-I 
expression, strongly suggests that escape-specific activators of development should have 
AP-1 binding sites in their promoters. With the recent completion of an annotated 
genome for A. limnaeus, it is now possible to evaluate genes that may be responsive to 
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AP-1. Further, the activation of transcription for the AKT signaling pathway rather late in 
the escape trajectory may indicate that this pathway is more important for the regulation 
of tissue growth and differentiation, rather than for regulation of developmental 
trajectory. 
Diapause-specific gene expression appears to point to an early role for the RAS-
MAPK-ERK pathway in mediating IGF signaling as well. However, it is worth pointing 
out that an apparent increase in expression in the diapause-bound embryos can be due to 
both a bona fide increase in expression, as well as a decrease in expression in escape 
embryos as is the case for IGF-I transcripts (discussed earlier). For example, the first and 
most consistently “upregulated” transcript in the diapause-bound embryos is MAP kinase 
binding protein 1 (MAPKBP1), a protein classified as active in the RAS-MAPK-ERK 
pathway (Glaab, Baudot et al. 2010). However, a proteomics study in murine C2C12 
myoblast cells identified MAPKBP1 as a protein that is strongly down-regulated in 
response to IGF-I signaling (King, Bouic et al. 2009). Thus, it is highly possible that 
transcripts found to be “upregulated” in the diapause-bound embryos are simply 
remaining stable in the face of more dynamic changes in the escape trajectory embryos 
that are responding to IGF signaling. Another major difference between the escape and 
diapause trajectories is the “upregulation” of several TBC proteins that are thought to be 
activated by AMP-activated protein kinase, and may play a role the regulation of 
metabolism (O'Neill 2013) associated with entrance into diapause. Interestingly, 
transcripts for STAT-3 and -5 are apparently upregulated in diapause-bound embryos. 
The implications of this are not yet known. 
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 One final transcript that deserves discussion is the apparent upregulation of 
FOXO3 in diapause-bound embryos at the 20 somite stage. Increased DAF-16/FOXO 
signaling has been shown to induce diapause-specific phenotypes in a variety of 
invertebrates (Greer, Dowlatshahi et al. 2007, Arden 2008, Gao, Wang et al. 2010, Hesp, 
Smant et al. 2015, Sim, Kang et al. 2015). However, to our knowledge this is the first 
report of upregulated FOXO expression in a vertebrate model of metabolic dormancy. 
This is a significant finding, and leads us to hypothesize that there is a common 
mechanism for regulation of diapause-like dormancies across all animals. The 
evolutionary implications of a common regulatory mechanism to induce dormancy in 
animals have far reaching implications. 
 
Conclusion 
 Large-scale gene expression profiling of diapause- and escape-bound embryos has 
revealed a number of interesting trends that agree with previous observations and with 
existing theory on the regulation of entrance into metabolic dormancy in a variety of 
animals. One of the most significant observations is the combined upregulation of IGF-I 
transcript and protein expression in concert with an upregulation of IGFBP2 early in 
development. These events all point towards an expected increase in IGF activity in 
escape embryos, and thus reinforce a role for decreased IGF-I signaling in the promotion 
of dormancy associated with diapause. Most if not all of the genes required for an active 
IGF signaling pathway are present in early embryos of A. limnaeus. The next steps will 
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require an examination of IGF regulators, such as GH, to explore the mechanisms that 
regulate the key differences in IGF expression that have been detailed in this thesis. 
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Table 4.1: Comparison of the vertebrate and invertebrate IGF/FOXO pathway 
 Complex* C. elegans† A. limnaeus Component Affects 
DAF-2 IGF1R IGF or Insulin receptor Receptor for IGF ligands 
DAF-16 FOXO FOXO family of Transcription Factors 
Transcription factor for 
arrested development 
related genes, and 
activator of growth 
regulatory elements 
SIR-2.1 SIRT Sirtuins 
Activation through 
AMPK and activates 
FOXO. Inhibits NF-Kb 






type 1  
Inhibitor of IGF1R and 
IRS 
AGE-1 PI3K Phosphatidylinositol 3-kinase catalytic subunit 




dependent protein kinase 
1b  
Activates AKT, IKK-β, 
and SGK 
IST-1 IRS Insulin receptor substrate 1/2 
Signaling adapter that 
couples activated 
IGF1R, activates PI3K 
GH Growth Hormone Ligand for GHR 
GHR Growth Hormone Receptor 
Activates JAK2, MAPK 
pathway, and release of 
IGF 
JAK2 Janus Kinase 2 JAK2 phosphorylates STAT proteins 
Sta-1 STAT1 
Signal transducer and 
activator of transcription 
1 
Transcription factor for 
growth related genes 
including IGFs 
Sta-1 STAT3 
Signal transducer and 
activator of transcription 
3 
Transcription factor for 
growth related genes 
including IGFs 
Sta-1 STAT5 
Signal transducer and 
activator of transcription 
5 
Transcription factor for 
growth related genes 
including IGFs 
LAR Receptor-type tyrosine-protein phosphatase F  
Inhibitor of IGF1R and 
INSR  
AKT-1 AKT V-AKT murine thymomaviral oncogene homolog
Activator of mTORC1, 
IKK-β, GSK-3β, and 
BCL-2. Suppressor of 
FOXO, p27kip1, BAD, 
and TSC1/2 
SGK-1 SGK Serine/threonine-protein kinase sgk-1 Inhibits FOXO 
IKK-β 
Inhibitor of nuclear factor 
kappa-B kinase subunit 
beta  
Inhibit FOXO and 
Apoptosis 
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 AAK-1 AMPK 
5'-AMP-activated protein 
kinase, catalytic alpha 
subunit  
Activated by energy and 
hypoxic stress and 
activates TSC1/2. 
 Complex* C. elegans† A. limnaeus Component Affects 
 BCL-2   
Activates survival and 
suppression of apoptosis 
 BAD  
Bcl-2-antagonist of cell 
death Activates apoptosis 
 Casp9  Caspase 9 Activates apoptosis 
 HAD-2 HDAC  
Deactylates DNA to 
suppress transcription 
 C44H4.6 GSK-3β 
Glycogen synthase kinase 
3 beta  
Activates the glucose 
metabolism pathway 
 TSC2  Tuberous sclerosis 2 
Complexes with TSC1 
and inhibits mTORC1 
 TSC1  Tuberous sclerosis 1 
Complexes with TSC2 
and inhibits mTORC1 
 Rheb-1 Rheb 
Ras homolog enriched in 
brain mTORC1 activator 
 CKI-2 p27Kip1 Cyclin-dependent kinase inhibitor CDK-1 inhibitor 




  RICTOR RPTOR independent companion of MTOR 
mTORC2 is a complex 
of RICTOR, mTOR, 
Deptor, mSin1, Protor, 
MLST8, TEL2, and 
TTI1. mTORC2 
activates AKT and 
promotes 
mobolity.mTORC1 is a 
complex of mTOR, 
PRAS4,0 Raptor, 
MLST8, and Deptor to 
form mTORC1, which 
activates S6K and 
transcription and 
proliferation.  
    TTI1 TELO2 interacting protein 1 
    TEL2 Telomere maintenance 2 
    Protor Proline rich 5 
    mSin1 
Mitogen-activated protein 
kinase associated protein 
1 
    Deptor DEP domain containing MTOR-interacting protein 
  Let-363 mTOR Mechanistic target of rapamycin 
  DAF-15 RAPTOR Regulatory associated protein of MTOR 
    PRAS40   
    MLST8 MTOR associated protein, LST8 homolog 
 R04A9.7 S6K Ribosomal protein S6 
Transcription of growth 
and proliferation related 
genes 
 CDK-2  
Cyclin-dependent kinase 
2 Phosphorylates Cyclins 
 Cyclin E  Cyclin E1 
Transcription of growth 
and proliferation related 
genes 
 Cyclin A  Cyclin A1 
Transcription of growth 




Src Homology 2 domain 
Containing transforming 
protein 2 
Signaling adapter that 
couples activated IGF1R 
SOS-1 SOS Son of sevenless 
Signal adapter that 
couples with GRB2 and 
SHC to activate RAS 
 Complex* C. elegans† A. limnaeus Component Affects 
Sem-5 GRB2 Growth factor receptor bound protein 2 
Signal adapter that 
couples with SOS and 
SHC to activate RAS 
Let-60 RAS Ras-like protein Signal protein that activates RAF 
Lin-45 RAF Raf-1 proto-oncogene, serine/threonine kinase a  
Signal protein that 
activates MEK1/2 
MEK-2 MEK 1/2 Mitogen-activated protein kinase kinase 2b 
Signal protein that 
activates ERK 
MPK-1 ERK Mitogen-activated protein kinase 1 
Signal protein that 
activates ELK1 and 
eIF4E 
Lin-1 ELK1 ETS domain-containing protein Elk-1 
Transcription of growth 
and proliferation related 
genes 
IFE-3 eIF4E Eukaryotic translation initiation factor 4 
Transcription of growth 
and proliferation related 
genes 
FOXM1 Forkhead box protein M Suppressor of p27kip1 
AP-1 is a complex of 
ATF, c-Jun and c-FOS 





C-Jun Jun proto-oncogene 
C-FOS Proto-oncogene protein c-fos 
*Complexes are highlighted when applicable.
† Names that appear only in this column and not the following means they are the same in both species.
(Kanehisa, Sato et al. 2016) 
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Figure 4.1 Summary of the number of mRNA transcripts identified in embryos of 
Austrofundulus limnaeus in this study. 
Data reduction was performed to better focus the exploration of IGF related gene expression. 
Differential expression of transcripts are discussed that are present in at least 2 FPKM with an 










































































Total Number of 
Transcripts
IGF Related Transcripts 
(>0 FPKM)
IGF Related Transcripts 
(>2 FPKM)
IGF Related Transcripts 
Adjusted P-value > 0.001
Transcripts (>2 FPKM)
IGF Related Transcripts
 P-value > 0.001
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Figure 4.2. Expression of insulin-like growth factor I and II transcripts in embryos 
incubated at 20ºC and 30ºC and developing along the diapause and escape trajectories, 
respectively.  
IGF-I transcripts are significantly upregulated in escape embryos compared to diapause-bound 
embryos starting at the completion of epiboly and through the 10 somite stage. Symbols are 























































Figure 4.3. Expression levels of plasma membrane receptors known to be active in insulin-
like growth factor signaling in embryos developing along the diapause (20ºC) and escape 
(30ºC) trajectories. 
Expression of mRNA transcripts is stage-specific, but not altered by incubation temperature and 












































































early 1-2 cell stage embryos, followed by IGF2R, with IGF1R exhibiting the lowest expression. 
Symbols are means ± s.e.m. (n=3).  
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Figure 4.4. Expression level of 
insulin-like growth factor 
binding proteins during 
development in embryos 
incubated at 20ºC and 30ºC 
and developing along the 
diapause or escape 
trajectories, respectively.  
There is an overall increase in 
the number of transcripts 
expressed for IGFBPs as 
embryos progress through 
development. There are also 
several IGFBPs that appear to 
be maternally packaged. 
IGFBP2 is significantly 
upregulated in escape embryos 
starting at the 16 somite stage 
(p-value < 0.001). Bars are 

























































































Figure 4.5. Expression of growth hormone (GH) and GH receptor (GHR) in embryos 
developing along the diapause (20ºC) and escape (30ºC) trajectories.  
Expression of both the hormone and receptor are similar for both developmental trajectories. 
GHR transcripts are highest in 1-2 cell stage embryos indicating significant maternal provisioning 
of this transcript followed by a large decline by the completion of epiboly. GH transcript levels 
increase during early development reaching peak levels around the 6 somite stage. Symbols are 



































































Figure 4.6. Differential expression of transcripts associated with the diapause or escape 
developmental trajectories.  
Statistical significance was set at an FDR adjusted P-value of 0.001, for transcripts expressed at 2 
FPKM or greater. Strong induction of genes that positively regulate the RAS-MAPK-ERK 
30˚ C
20˚ C
1-2 Cells Epiboly Neural Keel 6 Somites 10 Somites 16 Somites 20 Somites 24 Somites
RASGRF2 RASGRF2 RASGRF2 RASGRF2 RASGRF2 RASGRF2 FOXM1
RASAL1 RASAL1 Fosl1 Jun-B-like HDAC8 HDAC8
HDAC8 Jun-B-like Jun-B-like c-Fos-like AP1M1 AP1M1
HDAC3 c-Fos-like c-Fos-like IGFBP2 MAPK12 MAPK12







































TBC1D8B PREX2 RASSF2 RASSF2
GRB2 TBC1D8B RAF1 RAF1 RAF1
MAPKBP1-v1 MAPKBP1-v1 RAB2D MAPKBP1-v1 MAPKBP1-v1
MAPKBP1 MAPKBP1 MAPKBP1 TBC1D8B MAPKBP1 MAPKBP1 MAPKBP1







pathway are observed in escape trajectory embryos, while transcripts known to regulate AMP-
activated kinase and JAK-STAT signaling are upregulated in diapause-bound embryos at 20 and 
24 somites. 
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Table 4.2 Gene name key for Figure 4.6 
Gene key: 
AP1M’X’ - Adaptor protein complex 1 subunit MU 
BNIP’X’ -	  BCL2/adenovirus E1B 19 kDa protein-interacting protein 
c-Fos-like – Fos proto-oncogene
CCNA’X’ - Cyclin-A
CDK’X’ – Cyclin-dependent Kinase
CDK2AP - Cyclin-dependent Kinase Adapter Protein
CDKI’X’ - Cyclin-dependent Kinase Inhibitor
FOX’X’ – Forkhead Box
GRB2 - Growth factor receptor-bound protein 2
HDAC’X’ – Histone deacetylase
IGF-‘X’ – Insulin-like Growth Factor
IGFBP’X’ – Insulin-like Growth Factor Binding Protein
INPP’X’ - Inositol Polyphosphate-1-Phosphatase
IQGAP’X’ - Ras GTPase-activating-like protein
Jun-B-like - Transcription factor jun-B
MAPK’X’ – Mitogen-activated Protein Kinase
MAPKBP’X’- MAPK binding Protein
MARCKS - Myristoylated alanine-rich C-kinase substrate
PACSIN’X’ - Protein Kinase C And Casein Kinase Substrate In Neurons
PIK3CB - Phosphatidylinositol-4,5-Bisphosphate 3-Kinase, Catalytic Subunit Beta
PKC’X’ – Protein Kinase C ‘Subunit’
PREX2 - Phosphatidylinositol-3,4,5-Trisphosphate-Dependent Rac Exchange Factor 2
PTPN’X’ - Protein tyrosine phosphatase, non-receptor type
RAB’X’ – Ras related G proteins
RAF’X’ - RAF proto-oncogene serine/threonine-protein kinase
RASAL’X’ – Ras protein activator-like
RASGRF2 - Ras protein-specific guanine nucleotide-releasing factor 2
RASSF’X’ - Ras-association domain family
RHEB – Ras homolog enriched in brain
RHOV – Ras Homolog Family Member V
STAT’X’- Signal transducer and activator of transcription
TBC1D’X’ – TBC1 domain family member
TSC’X’ – Tuberculosis Sclerosis
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Chapter 5: Conclusions 
Development is a complex, life-long process that involves untold numbers of 
signaling molecules that regulate the formation and function of phenotypic characters. 
Both temporal and spatial gene expression patterns determine progress through 
development and the faithful reproduction of species-specific developmental patterns. 
While many patterns of gene expression during development are highly conserved across 
taxa, novel traits evolve through modifications to existing programs that yield novel and 
beneficial results. Thus, novel adaptive traits such as the ability to enter into a state of 
reversible metabolic arrest are likely rooted in small alterations to existing signaling 
pathways. Species-specific adaptive phenotypes can be achieved through a variety of 
mechanisms including mutation, epigenetic regulation, and alterations in sensitivities to 
environmental factors. In Austrofundulus limnaeus, the ability to enter into diapause, a 
state of metabolic and developmental arrest is associated with a suite of characters that 
include different developmental rates, differences in timing of major morphological and 
physiological events, and reprogramming of bioenergetics pathways. Importantly, many 
of these changes occur relatively early in the developmental program, during a time when 
theory suggests that selection pressure should favor conservation of function, rather than 
novelty. Further, the metabolic phenotype at the completion of embryonic development is 
unique for embryos that enter diapause compared to those that do not. These traits are 
known to be driven by different molecular and biochemical processes during 
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development as revealed through ongoing studies at the proteomic and transcriptomic 
levels. In this thesis I explored the role of insulin-like growth factor (IGF) signaling, a 
signaling program that is highly conserved across all multicellular animals, and its 
possible role in regulating developmental phenotype in embryos of A. limnaeus. 
 Insulin-like growth factors (IGF) I and II exert positive effects on rates of cellular 
growth, metabolism, and proliferation (Jones and Clemmons 1995, Baxter 2000). 
Blocking of IGF signaling has been shown to be an integral part of entrance into 
developmental dormancy in a variety of animals, the most well studied of which is the 
nematode worm, C. elegans (Kimura, Tissenbaum et al. 1997, Ogg and Ruvkun 1998, 
Honda and Honda 1999, Tissenbaum and Guarente 2001, Hesp, Smant et al. 2015). 
Downregulation of IGF signaling is also known to be associated with other forms of 
dormancy in a variety of species such as fish, insects, and mammalian hibernators (de 
Pablo, Perez-Villamil et al. 1993, Kenyon 2001, Schmidt and Kelley 2001, Genade, 
Benedetti et al. 2005, Donahue, Galley et al. 2006, Kenyon 2010, Kamei, Ding et al. 
2011, Lucas-Sánchez, Almaida-Pagán et al. 2014). Downregulation of the IGF pathway 
leads to a suite of characters such as decreased metabolic activity, decreased 
mitochondrial electron transport, decreased rates of protein synthesis, cell cycle arrest, 
and an increase in the production of enzymes that prevent oxidative damage and repair 
DNA (Honda and Honda 1999, Tran, Brunet et al. 2002). All of these traits are similar to 
characteristics documented in embryos of A. limnaeus during diapause (Podrabsky and 
Hand 1999, Podrabsky and Hand 2000, Podrabsky and Somero 2007, Podrabsky, 
Tingaud-Sequeira et al. 2010, Anderson and Podrabsky 2014). Many of these traits, 
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including the increase in DNA repair and ROS-mitigating enzymes have been shown to 
be regulated through the activity of the FOXO/DAF-16 transcription factor, which is 
activated through release of inhibition driven through IGF1R/DAF-2 activation (Dorman, 
Albinder et al. 1995, Kimura, Tissenbaum et al. 1997, Zheng, Yang et al. 2007, Hesp, 
Smant et al. 2015, Sim, Kang et al. 2015). This pathway appears to be conserved in 
various organisms that have a period of arrested development in relation to longevity 
(Kimura, Tissenbaum et al. 1997, Kenyon 2001, Genade, Benedetti et al. 2005, Kenyon 
2010). 
With all of these factors in mind, I investigated the possible role IGFs, their 
receptors, and related proteins that are affected through the IGF pathway in the possible 
regulation of diapause in embryos of A. limnaeus. First, I demonstrated that the IGF-I and 
–II proteins have stage-specific expression patterns during development, and these 
expression patterns are unique in embryos developing along the diapause and escape 
developmental trajectories. These differences in protein expression are due both to 
changes in embryonic expression patterns of IGF-I as well as through maternal packaging 
of IGF-II. These data illustrated upregulation of IGF-I and –II at specific stages of 
development in embryos along the escape developmental trajectory. However, given the 
role of IGFs in promoting cellular growth and proliferation, these data did not definitively 
link blockage of IGF signaling to diapause in A. limnaeus. To further connect a reduction 
in IGF signaling to diapause in A. limnaeus, we set out to pharmacologically inhibit IGF 
signaling through the insulin-like growth factor 1 receptor (IGF1R) under conditions that 
should induce the escape phenotype. Inhibition of IGF1R results in a diapause-mimic 
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state, even under conditions that should lead to escape embryo development. Many of the 
developmental characteristics of these embryos mimicked embryos developing along the 
diapause trajectory. However, the inhibited phenotype was not a perfect phenocopy of 
diapause, suggesting that IGF-I signaling was either not completely blocked, or the 
presence of other signaling pathways in the regulation of the diapause phenotype. 
Together, the protein expression data and pharmacological inhibition data suggest that 
blocking of IGF signaling is likely a necessary part of a larger suite of molecular signals 
that dictate entry into diapause. To further investigate the IGF signaling pathway in the 
regulation of diapause in A. limnaeus I explored a large transcriptomic data set generated 
for embryos developing along the diapause and escape trajectories. 
To focus my studies, I took a large transcriptomic dataset for diapause- and 
escape-bound embryos and filtered the data for all genes known to be involved in the IGF 
signaling pathway in vertebrates. The genes evaluated ranged from cell signaling factors, 
and a variety of effector proteins, to the key proteins involved in the regulation of the IGF 
pathway including growth hormone signaling and the association processes that lead to 
IGF transcription and exocytosis. These analyses lead to a relatively small number of 
genes that are differentially expressed in embryos developing along the two 
developmental trajectories. However, within this small set of differentially expressed 
transcripts are potent regulators of IGF signaling that seem to suggest how IGF signaling 
may be exerting its effects on accelerated rates of development associated with the escape 
trajectory. From these data it is clear that the RAS-MAPK-ERK signaling pathway is 
likely to be a major regulator of early IGF signaling in both developmental trajectories, 
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with the AKT/Protein Kinase B signaling pathway becoming more important later in 
development, after developmental trajectory has already been established. Importantly, in 
terms of IGF-I expression, the transcriptomic data is consistent with the protein data. 
Additionally, transcripts for a positive regulator of IGF activity, IGFBP2, has been 
identified as a likely candidate for increasing IGF signaling in embryos along the escape 
trajectory. (Myers, Lin et al. 2015, Park, Kim et al. 2015). This combined information 
suggests that early expression of IGF-I and increased half-life of IGF-I without blocking 
receptor binding through the action of IGFBP2 may support escape embryo development. 
In addition to these added insights, a number of other genes upregulated in both 
trajectories have been identified that deserve further investigation.  
The data presented in this thesis set the stage for a more complete and informed 
investigation of the cellular signaling pathways that may regulate diapause in embryos of 
A. limnaeus. Diapause is an intriguing developmental process that occurs in various
species from vertebrates to invertebrates and is characterized by diverse suite of 
characters involving arrest of cellular processes, and a concomitant increase in tolerance 
of environmental stress.  
 I would propose more manipulation experiments, specifically overexpression of 
IGFs in diapause-bound embryos. By investigating how increased IGFs affect diapausing 
embryos we could determine if IGF downregulation is necessary for embryos to enter 
diapause. In addition, investigation of additional regulators of development such as 
growth hormone (GH) or 5’-AMP activated protein (AMPK) appear to be promising 
areas for future studies (Salvatori 2004, MacRae 2010). Exploring more deeply the 
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function of IGF regulated genes that have been identified in other species might also lead 
to a better understanding of the suite of signals necessary to support entrance into 
metabolic depression and survival in diapause.  
Growth hormone signaling is an especially promising target of interest, because of 
its role in regulating IGF transcription and secretion (Davey, Xie et al. 2001, Salvatori 
2004). GH controls growth largely through regulating IGF concentrations, but it also has 
been shown to act independent of IGF signaling. For example, GH is thought be be 
involved in increased lipolysis and stimulation of metabolism during periods of food 
deprivation (Clemmons 2004). Also, it has been shown that GH and IGF-I stimulate 
embryos during early development in mammals and are critical in the proper formation of 
the blastocyst (Palma, Muller et al. 1997, Moreira, Paula-Lopes et al. 2002). Due to the 
nature of the relationship of IGF and GH expression, and their possible synergistic 
effects, exploring GH expression and inhibition in developing A. limnaeus embryos is 
very likely to provide useful information on the molecular regulation of diapause in this 
species. For example, the increase of IGF-I protein observed in escape embryos after 
epiboly may correlate with a spike in GH or the effects of IGF-I may be enhanced 
through GH signaling. Studies into the expression of GH during A. limnaeus development 
are already underway. 
Blocking of the IGF signaling pathway is almost certainly one of the key 
components for regulating entrance into diapause in A. limnaeus, but it is most likely not 
the only pathway that regulates entrance into diapause and the diapause phenotype. In C. 
elegans, it is abundantly clear that regulation of IGF-I and the insulin pathway are 
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important for dauer formation, but it has also been shown that other signals regulate 
many aspects of C. elegans cell identity, function, and survival in the dauer state. 
Transforming growth factor-beta (TGF-beta) superfamily ligands are one such group of 
signaling molecules that regulate dauer phenotype in C. elegans (De Robertis 2008). The 
TGF-beta superfamily is a large group made up of many signaling factors that are known 
to be key regulators of growth such as activin, Nodal, growth and differentiation factors 
(GDFs), and bone morphogenetic proteins (BMPs) (Herpin, Lelong et al. 2004). There 
are many TGF-beta signals identified in C. elegans such as DBL-1 and DAF-7 with 
receptors such as SMA-6, DAF-1, and DAF-4 (all serine/threonine kinase receptors) (ten 
Dijke and Hill 2004). These signaling factors activate receptors and the SMAD pathway, 
which in C. elegans has been shown to increase body size, tail development, and dauer 
(Suzuki, Yandell et al. 1999). Ren et al. found that DAF-7 expression decreases when 
larvae enter dauer dormancy, but then increases during exit from the dauer state. 
Additionally, DAF-7 loss of function mutants spontaneously enter dauer dormancy 
(Gumienny and Savage-Dunn. 2005). TGF-beta signaling is important in vertebrates as 
well, and thus it is possible that parallel pathways may be acting in A. limnaeus to 
promote active development, and thus be blocked during entrance into diapause. Another 
possible target is the homolog of DAF-11, a guanylyl cyclase related gene that also 
inhibits dauer formation in C. elegans (Thomas, Birnby et al. 1993). The data required to 
initially explore these pathways is already available, and through a more global analysis 
of gene expression patterns in diapause- and escape-bound embryos it may be possible to 
highlight the possible routes through which diapause and development are regulated in A. 
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limnaeus. While additional transcriptomic analyses may allow for some pathways to be 
eliminated from consideration due to a lack of expression, almost certainly more 
proteomic and functional work will be required to verify if hypotheses generated from 
transcriptomic data actually lead to functional phenotypic differences.  
The data we have gathered concerning IGFs and IGF signaling in A. limnaeus 
embryonic development have shown that the IGF signaling is differentially regulated 
during entry into diapause in this species. This data is the first of its kind that actually 
shows this relationship of IGF and arrested development in vertebrates. These data 
suggest an evolutionary conservation of insulin-like signaling in the regulation of 
dormancy across all animals. However, these studies are only the first steps in elucidating 
the role of IGF signaling in the regulation of diapause in A. limnaeus. Future work will 
need to be focused on the many ways that IGF signaling may be regulated in these 
embryos.  In addition, the possible role of other signaling pathways in regulating tissue-
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